ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001038.1|Pyralomicin_1 # 1 # 690 # -1 # ID=1_1;partial=10;start_type=GTG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.726	BGC0001038.1|Pyralomicin_1 	1	690	-	Loose	1300	110.153	optrA	29.41	3003746	protein homolog model	n/a	n/a	oxazolidinone antibiotic; phenicol antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	GTGGACCGGCTGACGTACGTGCTGCCGGACGGGCGGCTGCTCCTGCACGAGGTGTCGTTCCGTGTCGGTGACGGAGCGAAGGCCGGGTTGGTCGGGCCGAACGGCGCGGGCAAGACCACCCTGCTGCGGCTGATCGCCGGCGATGTGCAGCCGGACGACGGCCGCGTCGTCTCCTCCGGCGGGCTGGGCGTGATGCGGCAGTTCATCGGCAGCATCCGTGACGACCGCAGCGTGCACGACCTGCTGCTGTCGGTGGCCCCCGACCGCGTCCGCGCCGCCGCCTCGGCCCTGGTCCGGGCCGAGGCGGCGATGGCGGCCCGCGACGACGAGGCGGCCCAGCTCGCCTACGCCCAGGCCGCCGCCGACTATGCCGACGTCGGCGGCTACGACATGGAGGTGGTCTGGGACGTCTGCGCCACCGAGGCCATGGGCCTGTCCTACGACGAGGTCAAGGACCGTCCGGTCACCACACTGTCGGGCGGGGAGCAGAAGCGCATCGTCCTGGAGGCGCTGCTGCGCGGCCCGGACGAGGTCCTGCTGCTGGACGAGCCGGACAACTACCTCGACGTGGCCGGCAAGCTGTGGCTGGAGAGCCGGTTGCAGGCCACGCCCAAGACCGTGCTGCTGGTCTCGCACGACCGCCAGCTCCTGGCCAACGCCGCCGACCGGATCGTCACCGTGGAGGACCGC	MDRLTYVLPDGRLLLHEVSFRVGDGAKAGLVGPNGAGKTTLLRLIAGDVQPDDGRVVSSGGLGVMRQFIGSIRDDRSVHDLLLSVAPDRVRAAASALVRAEAAMAARDDEAAQLAYAQAAADYADVGGYDMEVVWDVCATEAMGLSYDEVKDRPVTTLSGGEQKRIVLEALLRGPDEVLLLDEPDNYLDVAGKLWLESRLQATPKTVLLVSHDRQLLANAADRIVTVEDR	MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKTTLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDMENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADYKKPISEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRMFLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFRYKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTPLAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQISGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKRTNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFVQSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQYDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM	35.11	gnl|BL_ORD_ID|2069|hsp_num:0	2263			81	759	linezolid; chloramphenicol; florfenicol; tedizolid
BGC0001038.1|Pyralomicin_2 # 697 # 1515 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.686	BGC0001038.1|Pyralomicin_2 	697	1515	+	Loose	400	64.6994	tetR	31.73	3003479	protein overexpression model	n/a	n/a	tetracycline antibiotic	antibiotic target alteration; antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTCCCGCCACAACTGGCCCTTCTTGCGCTCGTCACTCTCTGGACCGATGGTCCAGTACAGGATCAGCGATCTGGAGTCTTGTCGTCATATTAGACTTCCGTCCGTGGATATGAGCAAGGCGGGACCGACGACAGGAGGCGCTGGGGGCGTATGGCTGCGGCCGGCCACTCGACCGGGGCGCGAAGGGCCGCCGCTCACCCGCGAGCGGATCATCGCCGAGGCGCTGGCCCTGCTCGACGAGGAGGGCGTCGACCGGCTGACCATGCGCCGGCTCGCCCAGCGGCTCGGCACCGGCTCCACCACCCTGTACTGGCACGTCAAGACCAAGGACGACGTGCTGGACCTGACGCTCGACATGATCTTCGGGGAGATCGAGATCCCCGCGCGGGACAACGGCGACTGGCGCGGCGCCGTCATCACGCTTGCCAACCGGTGGCGTGCGGTGCTGCTCAAGCACCCCTGGTCGGCGGTGCTGCTGGGCCGCCCCATGCTCGGCCCGAACGTGCTCACCCGCAGCGAGTTCCTGTACTCCACCCTGGTCAAGGCCGGTGTCACCGAACCCCACCTCACCGGCGCCGCCTACAGCCTGTCCAACTACATCATCGGATCGGCACTGATGCAGGCCACCTGGTCCACCAACGCCGAGCCGGGCGTGCGGCAGGCCGCTGGCGAGCACCTGCGTGCCAACCAGGACAGCTACCCGATTCTCGCCACTCACGGCCCCCTGGTCGCCGGTGACGACTGGGACACCGGCTTCGGCTTCGGCCTCACCTGGCTGCTCGACGGCATCGCGAAGGTCGCCGGCGCCGGCGCGTGA	MSRHNWPFLRSSLSGPMVQYRISDLESCRHIRLPSVDMSKAGPTTGGAGGVWLRPATRPGREGPPLTRERIIAEALALLDEEGVDRLTMRRLAQRLGTGSTTLYWHVKTKDDVLDLTLDMIFGEIEIPARDNGDWRGAVITLANRWRAVLLKHPWSAVLLGRPMLGPNVLTRSEFLYSTLVKAGVTEPHLTGAAYSLSNYIIGSALMQATWSTNAEPGVRQAAGEHLRANQDSYPILATHGPLVAGDDWDTGFGFGLTWLLDGIAKVAGAGA	MMSRLDKSKVINSALELLNEVGIEGLTTRKLAQKLGVEQPTLYWHVKNKRALLDALAIEMLDRHHTHFCPLEGESWQDFLRNNAKSFRCALLSHRDGAKVHLGTRPTEKQYETLENQLAFLCQQGFSLENALYALSAVGHFTLGCVLEDQEHQVAKEERETPTTDSMPPLLRQAIELFDHQGAEPAFLFGLELIICGLEKQLKCESGS	130.77	gnl|BL_ORD_ID|442|hsp_num:0	276			12	600	tetracycline
BGC0001038.1|Pyralomicin_3 # 1529 # 2368 # -1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.694	BGC0001038.1|Pyralomicin_3 	1529	2368	-	Loose	400	32.7278	vanR gene in vanA cluster	26.09	3002919	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	GTGAATATCGTGCCGACTGCTGGAAAACCGAGACAGATATTCGCGGTGCTGGCGCTGAACGCGAACAATATCGTGCCCGTTCGCGTGCTCATCGAGGAGGTGTGGGGCGAACGCCCGCCGCGCAGTGCCGGCACCACCTTGCAGACCTACGTCCTCCAACTGCGCAAACGGCTGGCCGTCGCGCTGGGCCGGAACGCGTCCCGCAGCCCGAAGGATCTGCTCGTCACCGCCAACGGCGGTTATCTCCTCTCGGTGCCGGCCGGATCGCGCGACATCGAGGACTTCGACCGCCTGACGGGGCGGGCCAGGCGCGCCGGCGATCCGGCCGAGGCTTTCCGGCTGTTCAACCAGGCGCTGGCGCTGTGGCGCGGATCGACCCTGGTGGACGTCCCGATCGGCCACACGCTCGAACGCGAGGTGGTCCGCCTGGAGGAGACCAGGACCAAGACGCTGCACGAACGCAACGAGATCGGGCTGCAACTCGGGCTGCACGCCGAACTGCTCGGCGAGCTGGCCGCGCTGAGCCGGAGCAACCCGATGGACGAGACCATCCAGGGACACTTCATCGTGGCCCTGTACCGGATGGGGCGCACGCTCGACGCGCTGGAGACCTACCAGCGCCTGCGCCGGACCATGGTCGAGGAACTGGGCCTGGAACCGTCGGACCGGCTGCGCGAGTTGCAGCGGGCCGTGCTCGCCTCCTCCCCGGAGCTGGACGTCCCGGCGGCCAGGCGGCGGCGGTTGGGGGCGGCCTCGCGCCAGGAGTGCCCGATGTGCGGCGGCAACTTCATCCGCGGCTGGCGGGCCCGTCAGGAGTTGATGGTCCCGCGCGTGTCGTGA	MNIVPTAGKPRQIFAVLALNANNIVPVRVLIEEVWGERPPRSAGTTLQTYVLQLRKRLAVALGRNASRSPKDLLVTANGGYLLSVPAGSRDIEDFDRLTGRARRAGDPAEAFRLFNQALALWRGSTLVDVPIGHTLEREVVRLEETRTKTLHERNEIGLQLGLHAELLGELAALSRSNPMDETIQGHFIVALYRMGRTLDALETYQRLRRTMVEELGLEPSDRLRELQRAVLASSPELDVPAARRRRLGAASRQECPMCGGNFIRGWRARQELMVPRVS	MSDKILIVDDEHEIADLVELYLKNENYTVFKYYTAKEALECIDKSEIDLAILDIMLPGTSGLTICQKIRDKHTYPIIMLTGKDTEVDKITGLTIGADDYITKPFRPLELIARVKAQLRRYKKFSGVKEQNENVIVHSGLVINVNTHECYLNEKQLSLTPTEFSILRILCENKGNVVSSELLFHEIWGDEYFSKSNNTITVHIRHLREKMNDTIDNPKYIKTVWGVGYKIEK	120.78	gnl|BL_ORD_ID|750|hsp_num:0	722			489	627	vancomycin; teicoplanin
BGC0001038.1|Pyralomicin_4 # 2536 # 3384 # -1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=GGG;rbs_spacer=7bp;gc_cont=0.776	BGC0001038.1|Pyralomicin_4 	2536	3384	-	Loose	550	24.6386	LRA-2	28.57	3002485	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	subclass B3 LRA beta-lactamase	GTGAACGGGCAGGGGCCTCTCGTGGGCCTCGCGGAATGGCGGCTGCCCTGCTCGGGCGAGCAGGCGCTGCGGCTGGCGGCGCGGGTCGGCGCCGAGGGGGTGCAGCTGGAGTTCGGCGGCCCCGGCCGGGGCGGGTGGGCCGACGCGCCGGGACGGGTCGGCGCGCTGCTGGAGACGTCGTCGGCGACCGGCGTCGCCCTCCTGGCCGTGGCCGGCAACGTGCTCAACGACCTGGGCCTGGCCGCATCGCCCGGAGGCCGGACCGAGTCACGGGTGCGGCGCGTGCTGGTCCGCCTGCTCGACACCGCGCGGGAGCTGCACGTCCCGCTGGTCCTGGTGCCGAGCTTCCGCCGCAGCGCCATCGACGGACCGAGGGCGTTCGCGCGCACGGCGCGCTTGCTGGCCTGGGCCGCTGCCGAGGCGGGCGCCCGCGGCCTGCTGCTGGCCAGCGAGAACGTGCTGGCCGACGAGGACGCCCGGGCACTGGTGGAGCAGGTCGCCTCCCAGGCCTTCCGCCTCGCCCTGGACACCTACAACCCGGTCACCGTCGGCCTCGACGCGGCACAGCTGGTCAAGGCGCTGGGCCCGGCACTCGCCGACCAGGTGCACCTCAAGGACGGCCCGCCGGCCGTGGGTGACATGCCCGCCCTCGGCATGGGGACGGCGCGGCTGGAGGAGACGCTCGCCGCGCTGGGCGCGCAGCGGCACCCCGTCCGGGCGCTCGTCCTCGAGAACGACTACCGCGACGGCCGCGCCGGCCGGATCGCCGCGGACCTCGCCTGGGCGCGCGCCGCGGCCGACCGCCACCGGCTGGCGACAGCGGATCAGACCCGCGGAACGGGCCCGTGA	MNGQGPLVGLAEWRLPCSGEQALRLAARVGAEGVQLEFGGPGRGGWADAPGRVGALLETSSATGVALLAVAGNVLNDLGLAASPGGRTESRVRRVLVRLLDTARELHVPLVLVPSFRRSAIDGPRAFARTARLLAWAAAEAGARGLLLASENVLADEDARALVEQVASQAFRLALDTYNPVTVGLDAAQLVKALGPALADQVHLKDGPPAVGDMPALGMGTARLEETLAALGAQRHPVRALVLENDYRDGRAGRIAADLAWARAAADRHRLATADQTRGTGP	MMDGIKKKTAAGAAAGSLLMMLGVFATPAAGGEAAFKDCPQCAQWNQQRKPFRIYGNTYFVGTAGLSSILVTSDYGHVLIDGGLAQSAPLIKANIEALGFKLTDVKAILVSHVHPDHAGGVAELQRQSGAQVYALRTAEAVLRTGRLTQDDPQSASKTATITPVPQVWVVQDDQLLGVGALRMRAIATPGHTPGGTSWTWDACEDGNCLKMIYADSLSAVAAGKYRFKDHPEVLQAFASSFSRAESAPCDVLLTPHPDASQLFQRLDPEGGTRAASIKDDTACRRYVQAARDTLARKLASEG	93.38	gnl|BL_ORD_ID|1218|hsp_num:0	1324			153	354	
BGC0001038.1|Pyralomicin_5 # 3381 # 4202 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.753	BGC0001038.1|Pyralomicin_5 	3381	4202	-	Loose	450	25.7942	ANT(4')-Ib	26.92	3003905	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(4')	ATGATAGCTGACCGTGCGGAACCGCTGCGCGGACGGCGGGCCCTCGTCGTCGGCGGATCCACCGGCATCGGCCGGGCGATCGCCCAGGCCTGGTCCGACGCCGGCGCGCAGGTGGTCGTCTGCAGCCGCACCGAGCCCCGCGACGTGGCGTGGGAGTGGTGCCAGGTGGACCTGGCCGACCCGGGACAGGCCCGGGAACGCCTGAACAGGCTCGGCTCCGGCCGGCTCGACATGGTGTGCTTCTCGGCCGTCCACTACGGCGAGCGGCGGGCCAGGTTCTGCGACACCGCCGAGGCCGAGTGGCGCCACCAGCTCGAGGTGAACGTCACCGGGCTCTGGCTCACCCTGGCCGCCACCCTGCCCGCGCTCCGCGCCGCGGCGCCCGGCCTGATGGTGGGGGTCTCCTCGGAGGTCGCGTTCAACGCGGGGCCGGAACGCAGCGGCTACGCCGCGACGAAGGCGGCGGCCAAGGCGTTGCTTGATTCGCTGGCGCAGGAGGAGGACCCCGCCGAGGTGCGGATCGTGCAGGTGCTGCCCGCGGAGATGGTCGACACGCCCGGCATCCGCAGACGGCGCGCGCCCGGCTTCGACTACGGCTCCTACATGCGGCCGGCCGCCTTCGCCCGGCTCGCCGTGGCGCTGAGCACCGCGCCGGGACCCGAATATCACGGCGAGAGCCTGGTGGTGGGCGAGGACGGCACCTGGTGGCCGGCCCACGCCCGAACACCCCGCTCCCAGAGCCGCCCCACGCCCCAGCCCACCCCCCGAAGCGCCCCCACCCCCTCCCGGCCCACGCCACCGAGCCGCCGGGGGCGGTCGTGA	MIADRAEPLRGRRALVVGGSTGIGRAIAQAWSDAGAQVVVCSRTEPRDVAWEWCQVDLADPGQARERLNRLGSGRLDMVCFSAVHYGERRARFCDTAEAEWRHQLEVNVTGLWLTLAATLPALRAAAPGLMVGVSSEVAFNAGPERSGYAATKAAAKALLDSLAQEEDPAEVRIVQVLPAEMVDTPGIRRRRAPGFDYGSYMRPAAFARLAVALSTAPGPEYHGESLVVGEDGTWWPAHARTPRSQSRPTPQPTPRSAPTPSRPTPPSRRGRS	MNMNGPASMAQKERLQTCQEIAKRLHEVYGNDVLAIGVYGSVSRGTDGPFSDIEMFCVLRDSAETVDKSYEWSAGPWKAEVNVCSASILLKDAATVEDRWPLTHGPYFSPLRLYDPEGFFQRLRLAAESPTKEDFRQAIHEILVGEMYEYVGKLRNVNRNGPSTYLPSLALRFAHYGAMLIGLHNQTLFSTGAMVLPEALKLPHRPKGFDHVAELAMSGDLAQPAKIVSACEDFWKGLVAWAAEHDYVIHSKRIPF	106.64	gnl|BL_ORD_ID|2143|hsp_num:0	2383			60	216	dibekacin; amikacin; tobramycin; isepamicin
BGC0001038.1|Pyralomicin_7 # 5508 # 6521 # -1 # ID=1_7;partial=00;start_type=TTG;rbs_motif=AGGGGA;rbs_spacer=7bp;gc_cont=0.761	BGC0001038.1|Pyralomicin_7 	5508	6521	-	Loose	300	25.7942	tet(44)	35.29	3000556	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	TTGTCGCAGTCGATCGCGGTCCTGGACGTGGGAGGCACGCACCTGCGCTGGGCCACGTGGAGCCGGCGGGGCGGGCTGGCCGCCGTCCGGCGGGTGGCCACACCCAGCCTGGCCAACGGAGCCGCGGAGCCGGTGGACGAGCTCCGAGCGCGCCTGGTCTCCGCCATGGCCCAGGCCGTGCCGGTGGACGGCGTGGCCGGCGTGGCCTTCGGCGCCGCCCTGGACCACCGCTCGGGAATCGTCTACGCCTCCGCCCCGCTGTGGGGCTCGTGCACCCGCCCCTTCGACCTGGCCGGCGCGCTGGCCCGGGCCAGGCCGGACGTCCGCTGGCACGTCGTCAACGACGTGACGGCGGCGCTGCTGCATCTGGCAGCCGGGCCGGTCGGCGCGAGCTGCCGCAAGCTGCTGCTCGTCACCGTCAGCACCGGGATCGCCGGCCGGACGCTCGACCGGCGCAGCGGCGAGATCCCGGTGGACGGCTGCGGCCTCCAGGGCGAGATCGGCCACCTGCCGGCCACCACCTCGATCGCCGGCCGGCCGGTCACGCTGGCCTGCGACTGCGGGCAACCGGACCACGTCTCCTCCTACTCCTCCGGGCCCGGTATCCGCCGGCTCGCCGCAGTCCTGCGGGAGCGGGACCCGGACGCCTGGCGCGGCAGCGCCCTCGACGGCCCGGGGCCGTTCGAGACGTTGCTGCCGGCCGCCCTCGACGCGGCTGACCCGGTGGCCGAAGAGCTGCTGCGGGCGGCGACGCGGCCCGTCGCGGACGTCGTCCGCTCCGCGCTGTGTCTCGACCCCGAGTTGGACGTCGTCGCGTTCACCGGTGGCGTCGTCCACGCGCTCGGCGCGCACTACCGCCGGGCGCTGCTGGCGCACCTGAACGCCCAGGGGATCTATCTCACCAGCGCGCTCGCCCCGGAGTCGATCACGGAGCGGTTGCTCGTGTGCCGTGAGGGAGAGGCCGATCCGCTGGTCGGCGCGGGCCTCGCCGCCGAGCGGACGGCCCGCTCATGA	MSQSIAVLDVGGTHLRWATWSRRGGLAAVRRVATPSLANGAAEPVDELRARLVSAMAQAVPVDGVAGVAFGAALDHRSGIVYASAPLWGSCTRPFDLAGALARARPDVRWHVVNDVTAALLHLAAGPVGASCRKLLLVTVSTGIAGRTLDRRSGEIPVDGCGLQGEIGHLPATTSIAGRPVTLACDCGQPDHVSSYSSGPGIRRLAAVLRERDPDAWRGSALDGPGPFETLLPAALDAADPVAEELLRAATRPVADVVRSALCLDPELDVVAFTGGVVHALGAHYRRALLAHLNAQGIYLTSALAPESITERLLVCREGEADPLVGAGLAAERTARS	MKIINIGILAHVDAGKTTLTESLLYTSGAILELGSVDKGTTRTDTMFLERQRGITIQAAVTSFNWNDYKINIVDTPGHTDFITEVYRSLSVLDGAILVISAKDGVQAQTRILFHALQKMNIPTIIFINKIDQDGINLNNIYQNIKEKLSNDIIVMQNVTLTPEISIKNIIDLDDWDPVISKNDKLLEKYIVGEKLTIQELMYEEYRCVKKGSLFPIYHGSARNNIGTQQLIEAISNLFCSEMNENDSELCGRVFKIEYTDHKQRLVYLRLYSGTLHLRDTIILPEKKKVKLTEIYIPSNGEMIQTKTVCSGDIFIIPNNTLRLNDIIGNEKLLPCNVWNDKTVPILRTRIEPIKIEEREKLLDALTEIADTDPLLRYYVDTITHEIIISFLGTVQLEVICSLLIEKYHINIRIEDPTVIYLEKPLQKADYTIHIEVPPNPFWASIGLSITPLPIGSGIQYESKVSLGYLNQSFQNAVREGINYGLEQGLYGWEVTDCKICFEYGVYYSPVSTPSDFRFLAPIVLEQTLKKAGTQLLEPYLSFILFTPQGYFSRAYKDAQKHCAIIETSQSKNDEVIFTGHIPVRCINEYRNTLTLYTNGQAVFLTELKDYQIATCEPVIQSRRPNNRIDKVRHMFNKKEN	52.66	gnl|BL_ORD_ID|1197|hsp_num:0	1171			1716	1818	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0001038.1|Pyralomicin_8 # 6768 # 8003 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=AGGGA;rbs_spacer=5bp;gc_cont=0.695	BGC0001038.1|Pyralomicin_8 	6768	8003	+	Loose	900	26.1794	adeH	22.06	3000779	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCGGTATCGGCGCAGACTGATCAGATTCCCGAGCAGGGGTTGTTCGCATCCGAAGGGCCGGGTGGGCCATGGTGGCGGCTGAACACCAGGCAGCCGGTGAGCTACGAGGTGCGGCTGCACCCGCGGCTCCTCGACCCCGCAGACCCCACCCTGGCCGACGCGGGCGCCGCCGCCGCGCAGCCGGCGGGACAAGAGCGCCGCAGGCTTCTCGTCGTCGAGAGCACCGTGTACGAGCTGTACGGTTACGAGATCTCCCGGTATTTCACCGAGCAGAAGGTGGACTACGAGGTCCTGGTCATCGACGCGCACGAGCGCGTCAAGACGATGGACCTGGTCATGAAGGTGGTCGCGGCCATGGACGGGTTCGGCATCGTCCGGCGCGCGGAGCCGGTCATCGCCTTCGGCGGCGGCGTGCTGACGGACGTGGCGGGGCTGGCCAGCAGCCTCTACCGGCGCTCCACGCCACACGTCCGGGTGCCGACGACGCTGGTAGGCATGATCGACGCGGGGATCGGCGCGAAGACCGGGGTCAACCTCGGCCAGCACAAGAACCGGCTGGGCGCCTACCACCCGGCGGTGACCACGCTGATCGACACGCAGTTCCTGCGCACCCTGGACGAGCGCCACATCGCCAACGGCCTGGCCGAGATCCTCAAGATCGCTCTCATCAAGGACGCCGGGTTGATGGAGTTGCTGGAGAGCGACGGCGCCCGGCTCATCTCCGAGCGCATGCAGGCCGCTGACAGCCTCGACCAGGGGCGGGGCGCCAAGGAGGTGATCCGGCGCGCTATCCAGGGCATGCTGTCGGAGCTCCAGCCGAACCTGTGGGAGCACCGCCTGACCCGGCTCGTGGACTACGGCCACTCCTTCTCCCCTGCCATCGAGATGCGCGCGCTGCCCGAACTGCTGCACGGCGAGGCCGTCTGCGTGGACATGGCGTTCTGCACGGTGCTGGCGCGGCATCGGGGCTGGCTGACCCGGGAACAGCAGGACCGCATCATCCGGCTGATGGGCGAGCTGCGACTGCCCTCCTGGCACCCGGTGTGCACGTCGGCGCTGATCACCCGAGCCCTGCAGGAAACCACGCGGCACCGGGACGGCCGCCAGCGGCTCCCACTTCCCGTGGGCATCGGCCAGGCGTGCTTCGTGGATGACCTGAGCGACACCGAACTGGTCGCCGCTCTGGCCGAGCTGCGGGAGCTGGGGCACCTGCGCGAGGACGTCGCCCTCTGA	MPVSAQTDQIPEQGLFASEGPGGPWWRLNTRQPVSYEVRLHPRLLDPADPTLADAGAAAAQPAGQERRRLLVVESTVYELYGYEISRYFTEQKVDYEVLVIDAHERVKTMDLVMKVVAAMDGFGIVRRAEPVIAFGGGVLTDVAGLASSLYRRSTPHVRVPTTLVGMIDAGIGAKTGVNLGQHKNRLGAYHPAVTTLIDTQFLRTLDERHIANGLAEILKIALIKDAGLMELLESDGARLISERMQAADSLDQGRGAKEVIRRAIQGMLSELQPNLWEHRLTRLVDYGHSFSPAIEMRALPELLHGEAVCVDMAFCTVLARHRGWLTREQQDRIIRLMGELRLPSWHPVCTSALITRALQETTRHRDGRQRLPLPVGIGQACFVDDLSDTELVAALAELRELGHLREDVAL	MVITSKQNWLLSSLMGSLLLAGCSLAPEYQPAKVIVPVKFKESDPKLEDNNWKIAQPADQQTRGEWWRIYNDAQLNELEQQAIAGNQNLKAVAANIQASRALRSAAQAERLPSIDAGFGPTRQKPSPASLGLDDNAHTSAQTLWRAQANVSYELDLFGRVASSVNAATADLQQQEALYQSALLALQADVAQGYFLIRQLDTEQAIYNRTIKLLGETRDLMQLRFKNGLVSELDVSRAQTELATAQTTALNIARNRASAEHALAVLLGKPPADFNLAVQPLTANSIRLPAGLPSTLLERRPDIAAAERAMAADNARIGIARAAFFPKLSLTGALGYESSSLSELGKWSSRTFLLGPVAGTILSLPLFDGGQRKAGVAQARAAYEESVANYRQTVLNAFREVENGLSDQRILDQQIQAQNQALSSSRHANQLSHLRYREGAISYLDVIDSDRTILQQEQLAAQLKGSQIIASINLIRALGGGWSS	85.09	gnl|BL_ORD_ID|493|hsp_num:0	542			108	507	tetracycline
BGC0001038.1|Pyralomicin_9 # 8184 # 8747 # 1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.720	BGC0001038.1|Pyralomicin_9 	8184	8747	+	Loose	700	27.7202	LHK-5	38.46	3006939	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	LHK beta-lactamase	GTGCGCATGCTCCGTTCGCGTCTGATGTACCGCAACGCGTGGATGTCGGTGCGGGAGGACGACGTCGAGCTGCCGGACGGCTCGGTCGGCCTGTACGGCGTGGTCGACAAACAGGACTTCGCCCTGATCATTCCCGCCGAGAACGACGGTTTCCACATCGTGGAGCAGTTCCGCTACCCGGTCGCCGACCGCTGCTGGGAGTTTCCGCAAGGGTCCTGGCCTGCCCATGCCCCGGGCGAGCCCGGCCCGGGACGGTCGCTGCCGGCGGAGGCGGTCCGCCTGGCCGCCATGGAGCTGCGCGAGGAGACCGGCCTGTCCGCTTCGTCCTTCACCCACCTGGGGCGCGTCCACGCCGCGCACGGCTATTCCAGCCAGGGCTGTCACGTGTTCCTGGCCGAGGGGCTCACCCGGGGCCGGCCGCAGCGCGAGGCCACCGAGGCCGACATGCGGCAGCTCTGGGTGAGCGAGAGCGACCTCGACGACATGGTGGCCACGGGACGCTTCGTCGACGCCATGTCGCTGGCCGCGCTGGCCCTGCTCGGCCGGGCCCGCCGGGCCCGCTGA	MRMLRSRLMYRNAWMSVREDDVELPDGSVGLYGVVDKQDFALIIPAENDGFHIVEQFRYPVADRCWEFPQGSWPAHAPGEPGPGRSLPAEAVRLAAMELREETGLSASSFTHLGRVHAAHGYSSQGCHVFLAEGLTRGRPQREATEADMRQLWVSESDLDDMVATGRFVDAMSLAALALLGRARRAR	MKKRITPFSRFASKGLSACSAGMLLVTVAHAANTAAAPAGMDAMVQTVMQAHQIPGMAIAIIQPGKTTYHNYGVASRETGQPVRETTLFEIGSLSKPFTALVAQRAETEGRIDLSAPASRYVTALRGSAFDRITLRQLGTYSAGGLPLQFPDNVTTPADVLAYYRHWQPVHPAGTTRLYSNPSIGLMGLAASLATGESFAGLLGTTVLQPLGMNSTYLQVPPEARSRYAMGYTAAGKPVRVNPGPLDEETYGVKSTTADMVGFLLAHMDPARSKGALRSALQQTRVPVYCAGQTRQGLGWESYQDWKNLDMLLAGNSNQMVFEPQLVKACPAGTMNEPNVWVNKTGSTAGFGAYAVFLPARQTGIVILANRNYPIADRIRLAHGILTALH	47.95	gnl|BL_ORD_ID|3680|hsp_num:0	4750			1059	1137	
BGC0001038.1|Pyralomicin_10 # 8811 # 9446 # -1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.686	BGC0001038.1|Pyralomicin_10 	8811	9446	-	Loose	390	56.225	evgA	23.56	3000832	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGATGCTGGCAATGGATTCGCGCTTGATTCGCGGCGCCATCGCGGCCGTGCTGGAGCTCGAAGCCGACATCACCGTGGTGGGCGAGACCGATCGATGGGAATGCGTGCAGCGCACCGCTCAGCGCTGCCGTCCGGACGTCGTCGTCATCGACGCCGACATGAGCGGCGGCTCGGCCCTCACCGCCGTCACCCAGCTGCGCAAGCACACCCCCGCCTGCCGGGCTCTGCTGGTCACGGCGCACAAATCGCCCGAGCTGCTGCGGCGGGCGATGAAGGTGAACGTCTCAGGAATCCTGCTGAAGGACTCCTCGACGGACGAGCTGGCCCGGGGGATCAAGGCGATAGCCGCCGGCGAGCAGGTCGTCGACCAGGAGCTGGTCATCGCGGTGCTGAACGCGGAGCCGAACCCCCTGACCAAACGCGAGACGGACATCCTGCAGATGATCTCGACGGGCGCCGAGCCCGGCGAGGTGGCCAGGCGCCTCGGTCTGAGCATCGGCACCGTGCGCAACTACCTGGCCACCATCGTGACCAAGCTCGACGCGCGCAACCGGGTGGACGCGATCCGCATCGCCGAGGAGTCGGGCTGGCTGCTGCCCGCGGACGAGTCCGAGGCCCTGTTCGACGCCTGCTGA	MMLAMDSRLIRGAIAAVLELEADITVVGETDRWECVQRTAQRCRPDVVVIDADMSGGSALTAVTQLRKHTPACRALLVTAHKSPELLRRAMKVNVSGILLKDSSTDELARGIKAIAAGEQVVDQELVIAVLNAEPNPLTKRETDILQMISTGAEPGEVARRLGLSIGTVRNYLATIVTKLDARNRVDAIRIAEESGWLLPADESEALFDAC	MNAIIIDDHPLAIAAIRNLLIKNDIEILAELTEGGSAVQRVETLKPDIVIIDVDIPGVNGIQVLETLRKRQYSGIIIIVSAKNDHFYGKHCADAGANGFVSKKEGMNNIIAAIEAAKNGYCYFPFSLNRFVGSLTSDQQKLDSLSKQEISVMRYILDGKDNNDIAEKMFISNKTVSTYKSRLMEKLECKSLMDLYTFAQRNKIG	103.43	gnl|BL_ORD_ID|936|hsp_num:0	1015			33	603	erythromycin; cloxacillin; tetracycline; oxacillin; norfloxacin
BGC0001038.1|Pyralomicin_11 # 9587 # 9892 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=7bp;gc_cont=0.552	BGC0001038.1|Pyralomicin_11 	9587	9892	+	Loose	910	23.0978	smeS	37.14	3003067	protein homolog model	n/a	n/a	aminoglycoside antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCAGTGCAGGGCCGAAGTTTAGTGATCCATTGCGGAGAATATGGAATGTCATACACCGATGTCAACCCTTACATGCGCATATTGAGGTCAGCGGGAAATATTGCGGTCACCGCAAAACACGACGCACCAGGGACCGAAAGTCGGGATTGCTGCGAATACCGCATTTCCTCGTCCGCGCCCGACCTCCACAGCAAGTGCGTCCGGCCCACCGCGTTACTTGCTCCCACAAGACCGCACCAGTACATTGGTCCGCAACCGGATCAACGTTCCAGTGGTAGCTCAATGTTCAAGGAGCTCGTGTGA	MAVQGRSLVIHCGEYGMSYTDVNPYMRILRSAGNIAVTAKHDAPGTESRDCCEYRISSSAPDLHSKCVRPTALLAPTRPHQYIGPQPDQRSSGSSMFKELV	MAFAMAKFQLKFGLTAKTFLAIFTACLLVLAVNGIASRVAFQTGFLDYLNDQGDLRMQRLMPHLQREYREHGGWEHLHGDGDRWARLLRPDLAHGHEGPVPSLSDQTGVPSRLGLFDAQHRFVAGNPDATSDDEPHAVQVDGQTVGWLGMVPFQTVIATNDLNFYNTQVRAWWVIGIALLLVTVLLAWLVSRALRQRLAKLAAATHRLAAGDYATRIERTSDDELDALVNDFNRMAQALDDTERNRRAFIADISHELRTPLAVVRAELEAIEDGIRPLDRANLVGLQGEIRQLGKLIDDLHDLSMTQSGGLAYRFAPLDLVALLRSELNGMRVRFANAGLALEEDLPATPLQVSGDERRLQQVLANLLENALRYTHAGGRVRVQAARVPAGVQLVVEDTAPGVPPDKCALVFERFYRVESSRNRASGGSGLGLAISHNIILAHHGVIHAAPSPLGGLRVVITLPEPA	21.63	gnl|BL_ORD_ID|312|hsp_num:0	342			198	303	
BGC0001038.1|Pyralomicin_12 # 9889 # 11370 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.719	BGC0001038.1|Pyralomicin_12 	9889	11370	+	Loose	1000	194.512	efpA	34.31	3003955	protein homolog model	n/a	n/a	rifamycin antibiotic; isoniazid-like antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGAAGAGTGCGAGGAGCACGGGATCGACGGCGGCCGGCGCGACACGGTGGTGGGTCCTGGCCCTCGCCGGGACGGCCCAGCTGATGGTCGTGCTGGACTCCACGGTGGTCAACATCGCCCTCCCGTCCATGCAGGACGACCTGAAGATGTCCGACGCGACGCGCGGCTGGGTGGTGAGCGCCTACACCCTGGCGTTCGGCGGTCTTCTGCTGATCGGCGGCCGGCTGGCCGACCGCTTCGGGCAACGGCTCGCCTTCGTCGCGGGCCTGCTGGGCTTCGCCGCCGCCTCGGCGCTGGCCGGGCTGGCGCCCAACGCGCCACTGCTGTTCGCCGGGCGGGCCGCGCAGGGCGCCTTCGCCGCCCTTCTGGCGCCCACCGCGCTGTCCCTCATCACCACGACGTTCACCGAGGCCCGCGAGCGCACCACGGCGTTCGGGGTGTTCGGGGCGCTCACAGGGGTGGGAGCGGCCATCGGGCTGCTGGTCGGCGGGCTGCTCACCCAGTACCTGTCGTGGAACTGGTGCCTGCTGATCAATATCCCGATCACCGCGCTGGCGCTGGTGCGGGTGCCCGCCGTCATCCCGGCCACCACACCGGTGCGCGGCAGGCCGCTGGACCTGGCCGGGATGGCGCTGAGCATGCTGGGCATGCTGGCGATCGTCTATTCGCTGTCCGAGATGGCCACCCAGGGCTGGTCCAGCCCGCTCGTGCTGGCGTTCCTGGCCGTCGGCCCCCTGCTGCTGGTCGCCTTCATCGCCTGGGAGGCCAGAAGCAGGCATCCCCTCCTGCCGCTGCGCGTGCTGCGCGACAGGACGCGGGCCGGCGCCTTCCTGGCGATCGGGCTGCCGCAGGTCTCGATGTTCGGCTTCTTCCTCTTCCTGACCTACTACCTGCAGCAGATCCTGGGCTACAGCCCGCTGCAGACCGGCCTGGCCTTCCTGCCGCTGTCGCTGGCCATCGGCGTCGGCTCGACGGTGATCACCAAGATGCTCGAACCGAAGCTGAGCCCCCCGGCGCTCATCATCCCGGCCCTGCTCATGATGGCGGCCGGCATCGCGCTGCTCATCGGCGCGGGGCCCGGCGGGTTCTCCGTCTACCTGACGCTGCTGCTGCCCGCCGAGTTGCTCATCGGCCTCGGGCTCGGCTGCGTGATCGCGCCGTCGATCAGCATGGCCACGGCGGGCGTCGGCGCCGACGACGCCGGGGTGGCCTCGGCCACCGTCAACGTGGTGCAGCAGCTCGGCGGCGCGATCGGCATCGCGTTGCTCAACACCGTCGCCACCACCGCGGCCGCCGGTTACCTGGCGACGTCCGGCACGAGCGACGCCCGGGCCCGCGCAGACGCGATCATGCACGGGTTCAGCGTCTCGCTCGCCATCGCGGCCGCGATCGTCGTGGCGACCGCCGTGATCGCCGGCTTCATGCTGCGGTCCCGGGCCACCCTGCCGCTGCCGGAGAGTCGCGAGGAGGAGGTCGCTTAG	MKSARSTGSTAAGATRWWVLALAGTAQLMVVLDSTVVNIALPSMQDDLKMSDATRGWVVSAYTLAFGGLLLIGGRLADRFGQRLAFVAGLLGFAAASALAGLAPNAPLLFAGRAAQGAFAALLAPTALSLITTTFTEARERTTAFGVFGALTGVGAAIGLLVGGLLTQYLSWNWCLLINIPITALALVRVPAVIPATTPVRGRPLDLAGMALSMLGMLAIVYSLSEMATQGWSSPLVLAFLAVGPLLLVAFIAWEARSRHPLLPLRVLRDRTRAGAFLAIGLPQVSMFGFFLFLTYYLQQILGYSPLQTGLAFLPLSLAIGVGSTVITKMLEPKLSPPALIIPALLMMAAGIALLIGAGPGGFSVYLTLLLPAELLIGLGLGCVIAPSISMATAGVGADDAGVASATVNVVQQLGGAIGIALLNTVATTAAAGYLATSGTSDARARADAIMHGFSVSLAIAAAIVVATAVIAGFMLRSRATLPLPESREEEVA	MTALNDTERAVRNWTAGRPHRPAPMRPPRSEETASERPSRYYPTWLPSRSFIAAVIAIGGMQLLATMDSTVAIVALPKIQNELSLSDAGRSWVITAYVLTFGGLMLLGGRLGDTIGRKRTFIVGVALFTISSVLCAVAWDEATLVIARLSQGVGSAIASPTGLALVATTFPKGPARNAATAVFAAMTAIGSVMGLVVGGALTEVSWRWAFLVNVPIGLVMIYLARTALRETNKERMKLDATGAILATLACTAAVFAFSIGPEKGWMSGITIGSGLVALAAAVAFVIVERTAENPVVPFHLFRDRNRLVTFSAILLAGGVMFSLTVCIGLYVQDILGYSALRAGVGFIPFVIAMGIGLGVSSQLVSRFSPRVLTIGGGYLLFGAMLYGSFFMHRGVPYFPNLVMPIVVGGIGIGMAVVPLTLSAIAGVGFDQIGPVSAIALMLQSLGGPLVLAVIQAVITSRTLYLGGTTGPVKFMNDVQLAALDHAYTYGLLWVAGAAIIVGGMALFIGYTPQQVAHAQEVKEAIDAGEL	93.02	gnl|BL_ORD_ID|2188|hsp_num:0	2427			72	1380	rifampin; isoniazid
BGC0001038.1|Pyralomicin_13 # 11370 # 12515 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=9bp;gc_cont=0.746	BGC0001038.1|Pyralomicin_13 	11370	12515	+	Loose	1000	73.559	vmlR	31.05	3004476	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	GTGGCCCGTCTGGACGTGGCCGGTCTCACGTACGTACTGCCCGACGGGCGCACGCTTCTGGACAGCGTCTCCTTCGAGCTCGGCCCGGGGATCACGGCCGGGCTGGTCGGTCCCGCCGGGTCCGGCAAGTCCCTGCTGCTGCGGCTGATCGCCCGAGAGCTGCGACCCGCCGCCGGCCGGATCTCCACCGAGGGGGCGATCGGCTACCTGCCACAGGAGCGCGGCGCGACGTCCTCGCGCAGACAGGCGGCGCTGGAGACGCTGTTACGCGGGTCGCACGAACTGCTCCTGCTCGACGAGCCCGACGACCACCTCGACGTGAGCGGCAAGGAACGGCTGGAGGACCAGCTGCGCGGCAGCGCCAAGACGGTGTTGCTGGTCTCGCGCGACCGCCAGCTGCTGGCCAACGCGGCCAACCGGATCATCTTCCTGGACCAGGGCCGCCTCGGCACGCACGGCGGCGGCTACGCCACCTACAGCGGCTCCCGGTGCCCCCGGCCGGCGGACGCGGGTGGCGCCGAGCTCAGTGGCGAGCACGCCTTCACCTGCCGCCGGCTGCGGTTCGCCGGCCTGACGGCCCCTTTCGACCTGCGGGTCCGCTTCGGCGAGCGGGTCGCACTGCTCGGCTCCGACGCGGGCCGGGCTCTCTTCCTGTCGCTCCTGGCCGACCCGCCCGGCCTGGGGCAGGCCGCGGCGCCGTACCGGGGGATCCTCGACGTCCACCCTCGGGCGCGGGCGATGCGCCTCGATCACCGGTGGCCCGGGCCCGGGCTGAAGGGCCGGAGCGTGGCTGGCATCGTGATGGACCAGCGCCGGTGCGGGCGCGAGGAGGCCATGGCCCTGCTGACCCGCTACGGCATCTCCAGGGAGTGGATGCGGCCCTACGAGACGCTGCGCACCGCCCAGCGCCGGGCGCTGCGCATCCTGCTGGCCGAGGTCGAGGGGGTGAACCTGCTCCTGCTGTCCGACCCCACCGGGGATCTGGACGTTCCCGGCGCGGAGACCGTGCAGCACGCCGTCCGCGGCTTTCCCGGCGCCGTCGTCGCCAGCACGTGCGACCGCTGGCTGACCGCGGAGTTCCCGCGCCTGCTGCACTTCTGCGCCGACGGCCGGGTGCGCGAACCCGGGGCCGGCGCCCGGTGCTGA	MARLDVAGLTYVLPDGRTLLDSVSFELGPGITAGLVGPAGSGKSLLLRLIARELRPAAGRISTEGAIGYLPQERGATSSRRQAALETLLRGSHELLLLDEPDDHLDVSGKERLEDQLRGSAKTVLLVSRDRQLLANAANRIIFLDQGRLGTHGGGYATYSGSRCPRPADAGGAELSGEHAFTCRRLRFAGLTAPFDLRVRFGERVALLGSDAGRALFLSLLADPPGLGQAAAPYRGILDVHPRARAMRLDHRWPGPGLKGRSVAGIVMDQRRCGREEAMALLTRYGISREWMRPYETLRTAQRRALRILLAEVEGVNLLLLSDPTGDLDVPGAETVQHAVRGFPGAVVASTCDRWLTAEFPRLLHFCADGRVREPGAGARC	MKEIVTLTNVSYEVKDQTVFKHVNASVQQGDIIGIIGKNGAGKSTLLHLIHNDLAPAQGQILRKDIKLALVEQETAAYSFADQTPAEKKLLEKWHVPLRDFHQLSGGEKLKARLAKGLSEDADLLLLDEPTNHLDEKSLQFLIQQLKHYNGTVILVSHDRYFLDEAATKIWSLEDQTLIEFKGNYSGYMKFREKKRLTQQREYEKQQKMVERIEAQMNGLASWSEKAHAQSTKKEGFKEYHRVKAKRTDAQIKSKQKRLEKELEKAKAEPVTPEYTVRFSIDTTHKTGKRFLEVQNVTKAFGERTLFKNANFTIQHGEKVAIIGPNGSGKTTLLNIILGQETAEGSVWVSPSANIGYLTQEVFDLPLEQTPEELFENETFKARGHVQNLMRHLGFTAAQWTEPIKHMSMGERVKIKLMAYILEEKDVLILDEPTNHLDLPSREQLEETLSQYSGTLLAVSHDRYFLEKTTNSKLVISNNGIEKQLNDVPSERNEREELRLKLETERQEVLGKLSFMTPNDKGYKELDQAFNELTKRIKELDHQDKKD	69.65	gnl|BL_ORD_ID|2587|hsp_num:0	2907			18	585	lincomycin; virginiamycin S2
BGC0001038.1|Pyralomicin_14 # 12608 # 13444 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.722	BGC0001038.1|Pyralomicin_14 	12608	13444	+	Loose	550	29.6462	RlmA(II)	28.38	3001301	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGAACCGGCAACGCCACGACGAGATCGCGCGCTTCTACGACGACGTCACCGACCCCTACGTCGAAGCGTGGGACGGCAACCTGCACATGGGCTACTGGGAGACGGCGGCGGCGCGGCCGTCCATCGCCGAGGCGACCGACCGCCTCACCGGCGAGGTGCTCGACCGGCTGCGGACGAGCCCCGGCGACCACGTACTCGACGTCGGCTGCGGCATCGGCAAGCCCGCGCTCCGGCTGGCCCAGGAGCGCAAGGTCGACGTCGTGGGCGTGTCGATCAGCGAGCAGCAGATCGAGATCGCCGCCGCGTCGGCGCGGGCCGTCCCGGTGCCCACCCAGGTCTCCTTCCGCACGGCCGACGCCATGGACCTGCCCTTCCCCGACTCCAGCTTCGACGCCGTCCTGTCCTTGGAGGTGCTCCACCACGTGGCCGACCGCGCCAGGGCGCTGCGCGAGATCGCCAGAGTGGTGCGGCCGGGCGGCTCGGTCGTCATCGCCGACTTCGCGCTGCGTGCCCCGGTGCCCGAGGAGCACCGCGAACTGGTGGACCGGTTCGCCGCCGCCTGCAACCTGGTGACGCTGACCGAGATCGACGAGTACGTCGCGGAGTTCACCGGGGCGGGGCTGGAACTGGTCGAGGTGACGGACGTGAGCGAGCACGTACGGCCTTCCATGCGCCAGCACGCCGAGGCCATGGTGGCGGCCCGCGACCGCCTCGGCCCCGTCGTCGGGGCCGGCAACCTCGACCTGATGGTGGAGCTCACCGAGCGCTATGCCGAGCTGCCCCAGTTCGGCTACGTCATCCTGCGCGGCGAGGGCCGGCGGACAGCGGCGGCCTGA	MNRQRHDEIARFYDDVTDPYVEAWDGNLHMGYWETAAARPSIAEATDRLTGEVLDRLRTSPGDHVLDVGCGIGKPALRLAQERKVDVVGVSISEQQIEIAAASARAVPVPTQVSFRTADAMDLPFPDSSFDAVLSLEVLHHVADRARALREIARVVRPGGSVVIADFALRAPVPEEHRELVDRFAAACNLVTLTEIDEYVAEFTGAGLELVEVTDVSEHVRPSMRQHAEAMVAARDRLGPVVGAGNLDLMVELTERYAELPQFGYVILRGEGRRTAAA	MNTNLKPKLQRFASATAFACPICQENLTLLETNFKCCNRHSFDLAKFGYVNLAPQIKQSANYNKENFQNRQQILEAGFYQAILDAVSDLLASSKTTTTILDIGCGEGFYSRKLQESHSEKTFYAFDISKDSVQIAAKSEPNWAVNWFVGDLARLPIKDANMDILLDIFSPANYGEFRRVLSKDGILIKVIPTENHLKEIRQRVQDQLTNKEYSNQDIKEHFQEHFTILSSQTASLTKTITAEQLQALLSMTPLLFHVDQSKIDWSQLTEITIEAEILVGKAF	98.58	gnl|BL_ORD_ID|2052|hsp_num:0	2274			294	501	tylosin; mycinamicin
BGC0001038.1|Pyralomicin_15 # 13496 # 14596 # -1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=AGGGA;rbs_spacer=10bp;gc_cont=0.726	BGC0001038.1|Pyralomicin_15 	13496	14596	-	Loose	275	25.409	Streptomyces rimosus otr(A)	34.09	3002891	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAGGAAGACGACGACCAAGCTGCCCGACGGCCGCGAGCTGATCTACTACGACACCCGCGACGACGTGGTCAGGGATCCGGTGGACCCGCGTCCGGCCACCGCCCCGGCCAGGACGACCGAGATCCGCTACGACGCGCTGCGCGAGGAGTGGGTCCTGATCGCCGCCCACCGGCAGGGACGCACCCACCACCCGCCGACCGAGGAATGCCCGCTGTGCCCGTCCCCGGAGGGCAACAGCGAGATCATGGCCGACGACTACCAGGTGGCCGTCTTCGAGAACCGCTTCCCGGCCCTGGCCGGCGACGGCGACGCGGAAAGCGCCCGCGAGCGCCTGCACGCGCTGCGCCGGCCCGGCCAGGCGTGGCGGGCGGCGCCCGGGGCGGGCCGCTGCGAGGTGGTGTGTTTCAGCGCCGACCACGACCGCTCCTTCGCGGACCTGCCCGCAGAACAGGTCTCGCTCGTCCTCGACGTGTGGACCGACCGCACCGCCGAGCTGTCGCACCTGCCCGGCGTCGAGCAGGTGTTCCTGTTCGAGGACCGCGGCAAAGAGACCGGCATGAGCCTGGTCCACCCGCACGGGCAGATCTACGCCTACCCGTTCGTCACCCCGCGGACCCGGCGGGTGCTGGCGGCGGTGGCCGGGCACCGGTCCGCGACCGGCCGGAACCTCTTCGACGACCTGGTGGCCGCGGAGTCGTCCGACGGCAGGCGCCTGGTCGTCGAGGCCGAGCACTGGACGGCGTTCGTGCCGTACGCCGCGCACTGGCCCTACGAGGTGCACCTGTACCCGCGCCGCCGGGTGCCTGATCTGACCGGGCTGGACGACGCCGCCCGGGCCGAGTTCCCCGGCGTCTACCTCGACCTGCTGCGCCGCTTCGACCGGCTGTTCGGCGCCGCCGGTCCGGCGCCCTACATCTCCTCCTGGATCCAGGCACCGATCTCCGACCGGGAGGAGTTCGCCCTGCACCTGGAGCTGTTCACGGTGCGCAGGACACCCGCCAAGCTCAAGCACCTGGCCGGCTCCGAGCTGCTCATGGACGTCTTCGTCAACGAGATCCCGCCGGAGTCGGCCGCGGCCAGGCTGCGCGAGCTGGGGTGA	MRKTTTKLPDGRELIYYDTRDDVVRDPVDPRPATAPARTTEIRYDALREEWVLIAAHRQGRTHHPPTEECPLCPSPEGNSEIMADDYQVAVFENRFPALAGDGDAESARERLHALRRPGQAWRAAPGAGRCEVVCFSADHDRSFADLPAEQVSLVLDVWTDRTAELSHLPGVEQVFLFEDRGKETGMSLVHPHGQIYAYPFVTPRTRRVLAAVAGHRSATGRNLFDDLVAAESSDGRRLVVEAEHWTAFVPYAAHWPYEVHLYPRRRVPDLTGLDDAARAEFPGVYLDLLRRFDRLFGAAGPAPYISSWIQAPISDREEFALHLELFTVRRTPAKLKHLAGSELLMDVFVNEIPPESAAARLRELG	MNKLNLGILAHVDAGKTSLTERLLHRTGVIDEVGSVDAGTTTTDSMELERQRGITIRSAVATFVLDDLKVNLIDTPGHSDFISEVERALGVLDGAVLVVSAVEGVQPQTRILMRTLRRLGIPTLVFVNKIDRGGARPDGVLREIRDRLTPAAVALSAVADAGTPRARAIALGPDTDPDFAVRVGELLADHDDAFLTAYLDEEHVLTEKEYAEELAAQTARGLVHPVYFGSALTGEGLDHLVHGIRELLPSVHASQDAPLRATVFKVDRGARGEAVAYLRLVSGTLGTRDSVTLHRVDHTGRVTEHAGRITALRVFEHGSATSETRATAGDIAQAWGLKDVRVGDRAGHLDGPPPRNFFAPPSLETVIRPERPEEAGRLHAALRMLDEQDPSIDLRQDEENAAGAVVRLYGEVQKEILGSTLAESFGVRVRFDPTRTVCIEKPVGTGEALIELDTRTHNYFWGAPWVCASDRPSPARAITFRLAVELGSLPLAFHKAIEETVHTTLRHGLYGWQVTDCAVTLTRTGVRSPVSAADDFRKANARLVLMDALGRAGTEVHEPVSSFELEVPAARLSPVLAKLAELGATPGVPTAEGDVFRLEGTMPTSLVHDFNQRVPGLTQGEGVFLAEHRGYRPAVGQPPVRPRPEGPNPLNRDEYILHVLKRV	55.20	gnl|BL_ORD_ID|4807|hsp_num:0	1273			1860	1983	oxytetracycline
BGC0001038.1|Pyralomicin_16 # 14593 # 15915 # -1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=AGGGA;rbs_spacer=9bp;gc_cont=0.733	BGC0001038.1|Pyralomicin_16 	14593	15915	-	Loose	700	85.1149	oleI	26.35	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGGGACGGATCCTCGTCGCCACCACGCCGGGCGAAGGTCACGTGAACGGGATGGTGGAGGTGGCGCGCGCGCTCGTCCGCGCCGGCCACGAGGTGCGCTGGTACACGGGACGGGCCTTCCGTCCCAAGGTCGAGGCCGCCGGGGCCGTGTTCGTGCCCATGTCGCGCGGGCACGACTGGGGCGGCAGGACCAGGGAGGAGGCGTTCCCGCACCACGCGGGGCTGACCGGCGTGCGGAGCATGGTCGCGGCCTTCCGCGACATCTTCTTCCGCGCCGCCTACGGTCAGATGGTCGACATCCTGGAGATCCTGGACGAGTTCCCGGCCGACGTGATCGTCTCCGGTGAGACGATCTTCGGCGCCAACTTCGCCGCCGAGCGGCGCGGCATCCCGATCGCCTGGGTGGCCACCTCCATCTACATCTTCGGCAGCCGCGACACCGCTCCGCTCGGACTGGGCCTGCCCCCTGCCGCCTCGCCGGCCGGCCGGCTGCGCAACAGGGCGCTCAAGGTGCTCTCCCGCACGCTGCTGAAACCCCTGCGGGAGGTGCGCAGAGACGCCGACGTGACCCGCTCGCGGGCCGGGCTGAGACCGATCGGCGCCGGCCCGTTCGAGAACATCGTCCACCCACCCGACCTGTACCTGATGGGGACGGTGCCCTCCTTCGAGTACCCCCGCACCGACATGCTGCCGCAGACCCACTTCGTCGGGCCCTTCGTCGGCCCGCCGCCCCAGGGGTTCCAGCCGCCCGCCTGGTGGGACGAGCTGGACGGGCGCCGCCCGGTCGTCCACCTCACCCAGGGCACGGTGGCCAACGACGCCGGCCGGCTGCTGACGCCGGGCCTCAAGGCGCTGGCCGGCCTGGACGTGACGGTGGTGGCGACCACGGGTGTCCCCCCGGACACGCTCGACCTCGGCCCCCTGCCGGACAACGTGCGGCTGGAGCGGTTCGTCCCGCATTTCGAACTGCTGCCCCGAGTGGACGTCATGATCACCAACGGCGGCTATGGCGGGGTCAACACGGCGCTGTCGCACGGGGTCCCGCTCGTGGTCGCGCCGGCCACCGAGGAGAAGCACGAGGTCGCGGCCCGCGTCGACTGGGCAGGCGTGGGCATCGGGCTCAGCCGCCGCAACCTGTCGGCCGACGCGCTGCGCCGCGCGGTCAGCACGGTGCTGGCCACGGACTCCTACCGCCGCCGCGCCCGCCAGTTGCAGGAGGAGTACCGCAGACACGACGGGCCGCGGCGCGCGGTCGCGCTGATCGAGAGCCTGGCCGGGCTGCCGCAGTCCCGGCCCGCCGCCGAAGGGAGCCTGCGCGGATGA	MGRILVATTPGEGHVNGMVEVARALVRAGHEVRWYTGRAFRPKVEAAGAVFVPMSRGHDWGGRTREEAFPHHAGLTGVRSMVAAFRDIFFRAAYGQMVDILEILDEFPADVIVSGETIFGANFAAERRGIPIAWVATSIYIFGSRDTAPLGLGLPPAASPAGRLRNRALKVLSRTLLKPLREVRRDADVTRSRAGLRPIGAGPFENIVHPPDLYLMGTVPSFEYPRTDMLPQTHFVGPFVGPPPQGFQPPAWWDELDGRRPVVHLTQGTVANDAGRLLTPGLKALAGLDVTVVATTGVPPDTLDLGPLPDNVRLERFVPHFELLPRVDVMITNGGYGGVNTALSHGVPLVVAPATEEKHEVAARVDWAGVGIGLSRRNLSADALRRAVSTVLATDSYRRRARQLQEEYRRHDGPRRAVALIESLAGLPQSRPAAEGSLRG	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	103.77	gnl|BL_ORD_ID|1684|hsp_num:0	1824			60	1206	oleandomycin
BGC0001038.1|Pyralomicin_17 # 16096 # 17400 # 1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.707	BGC0001038.1|Pyralomicin_17 	16096	17400	+	Loose	1080	41.9726	rosB	27.44	3003049	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGCCGAAGGAAAACGCCGAATGGCAGATCATGACGACTGTCGCGGGCATCGGAGTGATCCTGCTGGTCGCGACCATGGTCGTCGTCGTCGCGCGATCAGTGCGGCAGCCGGCGGTGATCGGCGAGATCCTGGCGGGCGTCATCCTGGGGCCCAGCGTGCTGGGGCTGTTCCCCGGGGACCTGACCGGGCTCCTCTTCCCCGCCGAGCTGCGGCCGCAGTTGTCGGTCGTGGCGCAGATCGGGGTCCTGCTCTTCCTGTTCGTCGTCGGCTGGGAGTTCACCCCCGCCACCATCCGCGGCCACCGGCGCAGCACGGGCCTGATCTGGCTGTCGTCGATCGTGACCCCGATGCTGCTCGGCGTGGCGATGGCCTGGCTGCTGTACCCGCGCTACGGCGTCGTGGACGGCCGCCAGGTGGGGGCTGCTCGGCTTCCGCTCTACCTCAGCGTGGCCATGTCCGTGACGGCCTTCCCGGTGCTGGCCAGGATCATCTCCGAGTACCGGCTGCAGAGCAGCCGGGTAGGCGTGCTCGCCCTCGCGCTGGCCGCCGCCGACGACGTGTTCGCCTGGTGCGTGCTGGCCGCGGTCGTCGCCTTGGTCACCACCAGCGGCTCGGCGGCGCTCATCTCGGTACTGGCCTGGTCGGTGATCTACGTCGTGGCCATGTTCTGGGTGGTGCGGCCGCTGTTGACCTGGGCGTTCCAGCGGATGAGCGCGGCCCAGCCGTGGCCGGTCATGGTCACCGCCGCGGGGGTCCTGCTGTCGGCCTACGTGACCTCGGTGATCGGCATCCACGCCATCTTCGGGGCCTTCATGTTCGGTCTGGTGATGCCGCGCTCCCTGGCGCCCGCGCTGCGCGCAGCGGTGCAGGTCCCGCTCGAACGCGTCGGCCAGCTGCTGATGCCGGTCTTCTTCGTGGTCACCGGGCTCTCGGTCGACCTGACGACGATCACCGGGATGACGCTGCTGATCACCGTCGGCATCGTGGTGGCGGCCTGCCTGGGCAAGCTGGGCGGGGTCACCGCGGCCGCCCGGCTCAGCGGGCTCAGCCCCAGCGGCTCACTGGTGCTGGGCCTGCTGATGAACACCCGGGGCCTGACCGAGCTCGTGGTGCTCAACGTCGGTCTCGGGCTGGGCCTGCTCAGCACCGAGCTGTTCAGCGCCATGGTCGTCATGGCCGTGGTCACCACGGCGATGGCCGCCCCGTTGCTCTCCCTGACCCTGCGGTCCTCGGCCGCCGTGTCGTCCCGGCCGGATCTGCGTCAGGACGCCGGTCCGGCGGCGCCGGCCCTGCCCACCCACTGA	MPKENAEWQIMTTVAGIGVILLVATMVVVVARSVRQPAVIGEILAGVILGPSVLGLFPGDLTGLLFPAELRPQLSVVAQIGVLLFLFVVGWEFTPATIRGHRRSTGLIWLSSIVTPMLLGVAMAWLLYPRYGVVDGRQVGAARLPLYLSVAMSVTAFPVLARIISEYRLQSSRVGVLALALAAADDVFAWCVLAAVVALVTTSGSAALISVLAWSVIYVVAMFWVVRPLLTWAFQRMSAAQPWPVMVTAAGVLLSAYVTSVIGIHAIFGAFMFGLVMPRSLAPALRAAVQVPLERVGQLLMPVFFVVTGLSVDLTTITGMTLLITVGIVVAACLGKLGGVTAAARLSGLSPSGSLVLGLLMNTRGLTELVVLNVGLGLGLLSTELFSAMVVMAVVTTAMAAPLLSLTLRSSAAVSSRPDLRQDAGPAAPALPTH	MHHSTPLITTIVGGLVLAFLLGSLAHRLRSSPLVGYLAAGVLAGPFTPGFVADTSLAPELAEIGVILLMFGVGLHFSLKDLLAVKAIAIPGAVAQIAVATLLGMGLSHLLGWDLMTGFVFGLCLSTASTVVLLRALEERQLIDSQRGQIAIGRSIVEDLAMVLTLVLLPAFAGVMGNETTSLSQLFTELAITIGKVIAFITLMIVVGRRLVPWILAKTASTGSRELFTLAVLVLALGIAYGAVGLFDVSFALGAFFAGMVLNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILLREPLAVLASLAIIIFGKSAAAFILVRMFGHSNVYSTHHFCPWRKSVNLPFILAGLGISLGLMSEHGRNLVLAGAILSIMLNPLLFTLLDRYLAKNETMEDLILEEAVEEEKQIPGRFVQSCTVSRLWSGGSLLGAKLHAEGIPLVVIENSRPRVEALREQGINAVLGNAASADIMSLARLDCALVIILTIPNGYEAGEIVASARIKRPDLEIIARAHYDDEVVYISVRGANQVVMGEREIANSMLNMLKIETLTEEDKRPLCPI	77.09	gnl|BL_ORD_ID|466|hsp_num:0	507			18	882	polymyxin B; polymyxin B1; polymyxin B2; polymyxin B3; polymyxin B4
BGC0001038.1|Pyralomicin_19 # 18552 # 20027 # 1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=AGGGA;rbs_spacer=9bp;gc_cont=0.728	BGC0001038.1|Pyralomicin_19 	18552	20027	+	Loose	1000	142.895	almE	30.53	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGAAACTCCATCGGCTGCTCATCGAAAGCGCGCGGCGCACGCCTGAGGCCGTCGCCGTGCACGACCACGACGGCCCGGTGACCTACCGCGCCCTGGACGAACTGTCCGATCTCTACCTGTCCGCCCTGCGCCGGCGCGGCGTCGGCCGGGGCGATCGCGTCGTCATCTGGACCGGCAAGCACGTCCAGGCGATCGCGGTGATGCAGGCGGTGCTGCGCCTGGGCGCCGTCTACGTCCCGGTCGCCGGCGCCAACCCGGCGGCCCGGGTCGCCAGGATCGTCCGCGACGCCGCGCCCGCGCTGGTCGTCACCGACGAGGACGCTCCCGGACGGCTCCCCGCCGGGCACGGCCTGCCGCTCGTCGCCTGGCCGGAGCTGGCCGCCGGCGGCGACGCCGACGCCGGCGGCGGCCGGGGCGAGCTCTCCGCAGGGGGCGACGATCCCGCCTACATCCTTTACACCTCAGGCTCGACCGGCACGCCCAAGGGGGTGTGCCTGAGTCACCGCAACGCGCTCGCGTTCGTCGAGTGGGCGGTGCGGGAAATCCGGGTGGGGGCCGGTGACCGGCTCTCCAACCATGCGCCGTTCAACTTCGATCTGTCGGTTTTCGATCTGTATGCCGCTTTCGCGACGGGGGCCTCGGTCCACCTCGTACCTCCGGCGAGCGCCTACGCCCCGCACCAGCTCACGGACTTCCTCCACGAGCGCGCCATCACCGTCTGGTACTCCGTCCCCTCCGTCCTGACCCTGATGTGCCGCGAGGGGGGCCTGCTGGACCGGGAGCCGCCGCCGGGGTTGCGCGCCTGCGTCTTCGCCGGAGAGCCGTTCCCCCTGCAGCACGTGCGGGCGCTGCGCAAACACTGGCCCGGCGTCCGGCTGCTCAACTGGTACGGGCCGACGGAGACCAACGTCTGCACCTCCTACGAGGTGAGCGACGCGGACCTGGACCGCGACCGGCCGCTCCCCATCGGGCGCGCCTGCGCCGGGGACACGGTCACGCTGTCGTCCCCGGACGACGACGGAGTCGGGGAGATCGTCGTCGAGGGGCCGACCGTGATGCTGGGCTACTGGGGCGGCGAGAGGTTGACGGGCCCCTATCGGACGGGCGACTTCGGCCGTCTGGACGCCGACGGCGAGCTGCATTACGTCGGGCGGCGCGACCACCTGGTCAAGGTCCGCGGCAACCGGGTCGAGCTGGGCGAGATCGAGACGGCCCTGGGAGGGCTCGGCTCCGTCGCCGAGGTCGCCGTGCTGGCCGCCGGGGAGGGGGATCACGCGCGCTTGTACGCGTTCGTCGTCCCTGCGCCCGGCCGGCGCCCCTCCCTGTTGGAGGTCAAGCGTCACTGCGCGGGGCTGCTGCCCCCATACATGAACGTCGACCGCCTGCGGCTGCTGGAGACGCTGCCCAGGACCCCGAACGGGAAGACCGACCGAGCTCTGCTGCTGGCCATGACGGAGGAGGGCGGCCCTCGATGA	MKLHRLLIESARRTPEAVAVHDHDGPVTYRALDELSDLYLSALRRRGVGRGDRVVIWTGKHVQAIAVMQAVLRLGAVYVPVAGANPAARVARIVRDAAPALVVTDEDAPGRLPAGHGLPLVAWPELAAGGDADAGGGRGELSAGGDDPAYILYTSGSTGTPKGVCLSHRNALAFVEWAVREIRVGAGDRLSNHAPFNFDLSVFDLYAAFATGASVHLVPPASAYAPHQLTDFLHERAITVWYSVPSVLTLMCREGGLLDREPPPGLRACVFAGEPFPLQHVRALRKHWPGVRLLNWYGPTETNVCTSYEVSDADLDRDRPLPIGRACAGDTVTLSSPDDDGVGEIVVEGPTVMLGYWGGERLTGPYRTGDFGRLDADGELHYVGRRDHLVKVRGNRVELGEIETALGGLGSVAEVAVLAAGEGDHARLYAFVVPAPGRRPSLLEVKRHCAGLLPPYMNVDRLRLLETLPRTPNGKTDRALLLAMTEEGGPR	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	88.31	gnl|BL_ORD_ID|4935|hsp_num:0	5928			588	1617	colistin A; colistin B
BGC0001038.1|Pyralomicin_20 # 20024 # 20614 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.721	BGC0001038.1|Pyralomicin_20 	20024	20614	+	Loose	800	25.0238	ParS	64.29	3005067	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic efflux; reduced permeability to antibiotic	resistance-nodulation-cell division (RND) antibiotic efflux pump; Outer Membrane Porin (Opr)	ATGAGCGGATGGGAGATGTTGCCGATGGCCCTGGCCGGACCCGAGCCGTGCGCGACGCACGTGTTCCCGATGAACGGCGCCACCCAGGAGCGCGCCGAGGAGCGATTGCCGTCGGTGGACGCCGACACCTTCCGCACGGTCATGGGCTCCTTCGCCAGCGGCGTCTGCGTGGTCACCACCACCGGCGGCGACGGATCACCGCGCGGGTTCACCTGCTCGGCGGTGTGCAGCGTGTCCGCCGACCCGCCGCTGCTGCTGTCGTGCGTGAGCAACAAGAGCGGCACGCTCACCGCCGTGCTGGCCAGGGGCAGGTTCGCGGTGAACATGCTGGACCATCGGGCCAGGCGGGTCTCCCAGGTCTTCGCCTCCCCGGTCCCGGACAAGTTCGACCGGGTGCGCTGGGACCGCGGCCCGGTCAGCGGGATGCCGGTGCTGGCCGACGTCGTCGCCTACGCCGAGTGCGAGCTGGAGCGGGCGGTGACCACGGGCGACCACACGCTGCTGGTGGGCCGGCTGGTCGGTGGAAACCTGCGGTCCCACCGCCACCCCCTGGCCTACTGGCGCGGCGGCTACGCCGAAGTCCTGCGCTGA	MSGWEMLPMALAGPEPCATHVFPMNGATQERAEERLPSVDADTFRTVMGSFASGVCVVTTTGGDGSPRGFTCSAVCSVSADPPLLLSCVSNKSGTLTAVLARGRFAVNMLDHRARRVSQVFASPVPDKFDRVRWDRGPVSGMPVLADVVAYAECELERAVTTGDHTLLVGRLVGGNLRSHRHPLAYWRGGYAEVLR	MLRLFLRLYLLLALGFAAAIFVVDHVIDAFYDSIVENYHRDAVRGQAYSLVEKLAPLDQAGRQRQLEDWRPHYGLELSLTDARQAKLTQEEQALLDKNLLVVREDFTEFISRIDAGPQLLDIKLPPEPSLTPLFTVLAYILLGVLVGIALLVWVRPHWRDLETLRLAAQRFGDGDLSSRTRIFRRSDIRTLAQHFNQMADRIESLISNQRELTNAVSHELRTPISRLSFELEQLNKQVDAEVRHDLIEDMRADLGELEEMVSELLTYARLEHGNVGSHREIVDAASWLDSVVADVALEAEAAGVTCEISACQVEQIRIEPRFMARAVINLLRNAIRHAHSRVEIALLDQGDSCQIRVNDDGPGIPADARQKIFEPFSRLDDSRDRSTGGFGLGLAIVHRVAQWHGGYAEALETPQGGASFRLTWERPR	45.79	gnl|BL_ORD_ID|2790|hsp_num:0	3805			1191	1233	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; imipenem; chloramphenicol; norfloxacin; ofloxacin; gentamicin
BGC0001038.1|Pyralomicin_21 # 20696 # 22330 # -1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.728	BGC0001038.1|Pyralomicin_21 	20696	22330	-	Loose	600	28.8758	Streptomyces venezuelae rox	31.03	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGACCGTGGAAACTCCCAGCACCCCATTCGACGTCGCCGTCCTCGGCACCCACCTGGGCTGCGCCATGCTCGCGGCGATCCTGGCCAAGCAGGGAGTGCGCGTCCTCCTCGTGGACGCCGCCCCCGGCCAGGAGGAGTTCGCCGGGGAGACGACGGTGCCGTACACGGCGGAGGTCTTCTTCACTCTCGCCCGCCGCTTCGACATCCCCGAGCTCGCCGCCTTCGGGCTGACCAGCGCGCTGCCGTCGGAGATCCGGCGCTCCAGCGGGATCAAACGCAGCCTGGGCTTCCTGCACCACAGCGAGGGCCGCCAGCAGGTCCCCGAACAGGCCGTGCAGTTCAACGTCCCGGGCGAGCACGCCGAGTGGCACCTGTATCGCCCGCACGTCGACCAGCACGCCTGGACGATCGCCCGGCGCTACGGCGCGGTGGTCGTGCCGCACCGTCCCGCGGTCGCGGACGTGCGCGTCGGCGCCGGCGGCGCCGACGTGCTGCTGGCCGACGGCTCCCTGCACCGCGCCCGCTTCGTCGTGGACGGCAGCGGCGCGGGCTCCCCGCTGGTACGACGGCTGGGGGCCGAGGACGCGGCGCCGAAACTGCGCTCCCGGTCGCGGGTGCTGGCCACGCACATGTACGGGGTGCGGCCGTACGAGCAGTGCGTGCGGCAGGCGGACTACGTCAGCGCCACCGACTGGTCCATGGGCACGATCAGCCACCTGTTCCCCGGCGGGTGGCTCCAGCTGGCCCACTTCGGCAACGGCGAGGACCCGGTCAACCCGTTGACCAGCGTGGTGCTCAGTCTGGACCCGGGGCGGTACGCGGACCTGCCGGGCGACCCCGAGCAGGCATTCCGCGAGCTGGTGCGCCGCTTCCCCACCCTGGCCCGCTCGTTCAAGGACGCCGTCGCCGCCCGGCCGTGGACCGCCGCCCGGGTCTGGCAGCGCACGGCGGGACCGGCGTTCGGCGAGGGGTGGTTCCTGTTCGATCGCACCTTCAGCCGCAACGACCTGTTCCTGTCACGCGACGTCACCATGACGGCCGAGATGGTCCACGCGCTGGCGCCGGCGCTGGTCGAGGCGGCGCGGCGCGACGACTGGTCGACACCGGCGCTGCGGCGCGCGGCGCTGTTTCAGGAGCGGCTGGTCGACTTCAACGACCGGCTGCTCGCCGGCGCCCGCACCGCCACCACCGACTTCCGGTTGTGGAACGCCTACTCGCGGGTGTGGCTGCTGTGGTCGATGCTCTCGGCCCTGTCGCTCAAGAGCGCCCGCAACCGGTGCCTGGCGCGGGGGCGCTGGGAGGAGGTGGAGCGCTTCGGGGACGACGCGTTCTGGTTCCGCCCGCCTGACGGGCTGCCCGGGCTGCTGGACCGGGCGCTCGGAGAGCTGGCCGAGGTCGAGGCCGGCACGCGCTCGGCGAGTGCCTGCGCCGGCCGCCTGTTCACACTGCTGCGCCGGGCGCCGTTCGTGCCGCCGGTCTACCGGTTCGCCGATCCGGACGCCCGCTACTACCACTTCTCCACGGCGCGACGGCTGCGCATGCTGTTGTGGTCGAAGACCGTGGCGCCCGCCGAGTTCCGGACGATGATGACCAAGGAGAACCTCACCAACGTGCCGCCTCCCGCGATGCACTGA	MTVETPSTPFDVAVLGTHLGCAMLAAILAKQGVRVLLVDAAPGQEEFAGETTVPYTAEVFFTLARRFDIPELAAFGLTSALPSEIRRSSGIKRSLGFLHHSEGRQQVPEQAVQFNVPGEHAEWHLYRPHVDQHAWTIARRYGAVVVPHRPAVADVRVGAGGADVLLADGSLHRARFVVDGSGAGSPLVRRLGAEDAAPKLRSRSRVLATHMYGVRPYEQCVRQADYVSATDWSMGTISHLFPGGWLQLAHFGNGEDPVNPLTSVVLSLDPGRYADLPGDPEQAFRELVRRFPTLARSFKDAVAARPWTAARVWQRTAGPAFGEGWFLFDRTFSRNDLFLSRDVTMTAEMVHALAPALVEAARRDDWSTPALRRAALFQERLVDFNDRLLAGARTATTDFRLWNAYSRVWLLWSMLSALSLKSARNRCLARGRWEEVERFGDDAFWFRPPDGLPGLLDRALGELAEVEAGTRSASACAGRLFTLLRRAPFVPPVYRFADPDARYYHFSTARRLRMLLWSKTVAPAEFRTMMTKENLTNVPPPAMH	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	114.29	gnl|BL_ORD_ID|4833|hsp_num:0	5820			360	615	rifampin; rifaximin; rifapentine
BGC0001038.1|Pyralomicin_22 # 22350 # 24017 # -1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=AGAGG;rbs_spacer=10bp;gc_cont=0.674	BGC0001038.1|Pyralomicin_22 	22350	24017	-	Loose	600	36.965	Streptomyces venezuelae rox	23.28	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGAGAAACAGCAGCATGGAGAAGACCTTCTACGACGTCGCGATCCTGGGATCGGGCATCGCCGGCACGTTGCTGGGCGCGATCCTGGCCCGGCACGGCGCGAAGGTCCTCCTGGTGGACGCCGCCTCGCACCCCAGGTTCGCGGTCGGGGAGTCCACGATCCCCTACACCCTGCTCTACCTGCGCGCCCTGGCCGACCGCTACGACGTCCCGGAGATCAAGGCGCTGGCCACCTTCACGCAGACCAGGAAGACGCTCGGGGAGCGGTTCGGCGTGAAGCGGCACTTCGGGTTCCTGCTGCACCATGAGGGGCAGCCGCAGAACCCGCGCGAGACCAACGAGTTCAACACGCCGAAGAACCTGCTCAACGAGGCCGCACACTACTTCCGCCAGGACACCGACGCCTACCTGTTCCACGTCGCGATCAAGTACGGCTGCCGGGCGAGGCAGAATTTCCGGGTCGAGCAGATCGACTTCGACGACTCCGGCGTCACCGTCACCGGCCCGGACGCGCAGTACCGGGCCCGCTACCTGGTGGACGCCAGCGGCTTCCGTTCCCCGGTGGCGGACAAGTTCGGCCTGCGGGAGAACCCGTGCCGGCTCAAGCACCATTCGCGCTCGGTCTGGAACCACATGCTCGACGTCACTCCGACCGACGACCTGTTCCGGCACGGCAAGGAGAACCGGCCGCCGTTCCCCTGGTACGAGGGCACCGTCCACCACATGTTCGAGCGTGGCTGGGCGTGGGTGATCGCCTTCGACAACAACAAGTGGTCGACCAACCCGCTGTGCAGCGTGGGCATGACCGTCGACCCCCGGACCTACCCCAAGCCCGAGCACCTGACCCCCGAGGAGGACTTCTACGCGCTCGCCGCGCCCTACCCCGACATCGCCCGGCAGTTCGAGGGGGCCAAGGCTGTACGCGAGTGGGTGTCCACGCCGCGGCTGCAGTACTCCTCCAGCCGCTGCGCCGGCGACCGCTGGTTCCTGCTCTCGCACGCGGCCGGCTTCATCGACCCGCTGTTCTCCCGCGGCCTGTCGAACACCGCCGAGGCGGTGCACGCCCTGGCCTGGCGGCTGCTGGCCGCGATCAAGGAGGACGACTTCTCCGCCGAGCGCTTCGCGTTTGTCGAGCGCCTGCAGCAGAAGCTGTTCGACTACAACGACTCGCTGGTCAACGCCGCCTTCATCTCCTGGCGCGAGTACGACCTGTGGACCGCGGTGTTCCGCTTCTGGGCCTGGGGCGCGAACGCCGGCTGCTACCAGATCCAGCGTGCGCTCAGCCGGTTCGCGCAGGACGGCGACGACAAGCACTTCAGGGAACTGGAGAAGGCGCCGCACCTTGGGCACTACTGGGGCTTCAACGACGGCTTCGCCAAGGCCTACGACAGCATGGTCGAACAGGTGGACGCGGTCGAGGCCGGCCACCTCAGCCCGCGCGAGGCGGCCGACGACCTGTACAACCAGATGCACCATGCCGACTTCTGGCCCAAGCACTTCGGCTTCGCCGAGCGGGACGTGCGTTTCATCAGCCCCGGCCCCAAGACGTTCTTCAAGATGGCGCGCTGGGCGAAGACCGAGGCCGACCCCGAGCTGGGCACGCTCATGATCGAGACCGGGAAGGCGGCGTTGAAGTCCCGCTTCCTCAAGGGACGCAAGCTGTTCTGA	MRNSSMEKTFYDVAILGSGIAGTLLGAILARHGAKVLLVDAASHPRFAVGESTIPYTLLYLRALADRYDVPEIKALATFTQTRKTLGERFGVKRHFGFLLHHEGQPQNPRETNEFNTPKNLLNEAAHYFRQDTDAYLFHVAIKYGCRARQNFRVEQIDFDDSGVTVTGPDAQYRARYLVDASGFRSPVADKFGLRENPCRLKHHSRSVWNHMLDVTPTDDLFRHGKENRPPFPWYEGTVHHMFERGWAWVIAFDNNKWSTNPLCSVGMTVDPRTYPKPEHLTPEEDFYALAAPYPDIARQFEGAKAVREWVSTPRLQYSSSRCAGDRWFLLSHAAGFIDPLFSRGLSNTAEAVHALAWRLLAAIKEDDFSAERFAFVERLQQKLFDYNDSLVNAAFISWREYDLWTAVFRFWAWGANAGCYQIQRALSRFAQDGDDKHFRELEKAPHLGHYWGFNDGFAKAYDSMVEQVDAVEAGHLSPREAADDLYNQMHHADFWPKHFGFAERDVRFISPGPKTFFKMARWAKTEADPELGTLMIETGKAALKSRFLKGRKLF	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	116.60	gnl|BL_ORD_ID|4833|hsp_num:0	5820			0	489	rifampin; rifaximin; rifapentine
BGC0001038.1|Pyralomicin_23 # 24049 # 25710 # -1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=AGTGA;rbs_spacer=6bp;gc_cont=0.700	BGC0001038.1|Pyralomicin_23 	24049	25710	-	Loose	600	40.0466	Streptomyces venezuelae rox	26.52	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGACAGGGACCAGGCGCGGCAAGACGTCCGGCCAGTACGACGTGGCGATCCTGGGCAGCGGGATGGCGGGCTCGATGCTCGCCGCCGTCCTGGCCCGCAACGGGGTGGAGGTGCTGCTGGTCGATCAGGGCACCCATCCGCGATTCGCGGTGGGGGAGTCGACCATTCCCTACACCTCCGCCATGACGCGGATCATCGCCGACCGCTACCGCGTGCCGGAGATCGGGGCGTTAGCCAGCTTCAAAGGCATACAACGTCATATTTCGCGAAATTCCGGTATTAAGCAGAACTTTGGGTTCGTCTACCACCGCGAAGGGCGCCCGCAGAACCCGGAGGAGATCAACCAGCTCAAGATTCCCACCGCCCTGCGCACCGAGTCCCACCTCTACCGCCAGGACACCGACGCCTACCTGTTCGCCGTCGCCGTCCGCCACGGCGCCCACCCCCGGCCCGGCACCCGTATCGAGGAGGTGGACATCGACCCCGACGCCGGGGTCGAGCTGCGCGCGGCGGGCGGGGAACGCTTCCGCGCCAAGTACGTGGTGGACGCCGGCGGCTTCCGCTCGCCGCTGGCCGACCGCTTCGACCTGCGCGAGAACCCCACCCGCGCCCGCCACCACTCCCGCAGCCTGTTCACCCACATGATCGGGGTGCGCCCGTTCGACGCGGCCCCGGCGGCAGCGCTGCACCGCCAGCCCAGCCCCTGGCACAACGGCACGCTCCACCACGTCTTCGACGGCGGCTGGCTCTGGGTCATCCCCTTCGACAACCACCCCGGCTCGACCAACCCGCTGTGCAGCGTGGGGCTCACGCTCGACCCCCGGCGCTTCCCCCAGGAGGAGCCGGACCCCCAGCGGGAGTTCGACGGCTTCCTCAAGCGCTTCCCCGAGATCGCCTGGCAGTTCACCGACGCCGTCGCCACCCGCCCGTGGGTGTCGACCGGCCGGCTGCAGTACTCCGCCAAGCGCCTGGTCGGCGACCGCTTCTGCCTCACCTCGCACGCGGCCGGCTTCATCGACGCCCTGTACTCGCGCGGGCTCACCAACACCCTGGACGTGGTCAACGCCCTGGCCTGGCGGCTGATCGCGGCCGCCCGCGAGGACGACTGGTCCACCGAGCGCTTCTCCTACGTCGAGACGCTGCAGCAGGGCCTCTTCGACGTCCATGACGACCTGGTCTACAGCTCCTTCGTCGGGTTCAGGGACTACGAGCTGTGGAACGCCGTCTACCGCACCTGGAAGATCGGCACCGTGCTGGGCACGCTGGTCCTGGAGAACGCCCACACCGCCTTCCTGCGCACCGGCGACGACGGCCTCTTCCGCGAGCTGGAGCAGAGCGACCATCCTGGCTCCCCGTTCCCCATCAGCGACCAGTTCAACCAGTTCGGCCCCCTCACCCGCGAGCTGTGCCTGGCCGTGGAGAACGGCTCGCTGAGCCCGTCGGCCGCCGCCGCCAAGGTCTTCCACCACATCGAGGACGCCGACTACATCCCGCCGGTCTTCAACCTCGGTGACCCGGCCAACCACTTCTTCCACGCCACGCCGCCCAAGATGCTGGCCGCCGCCCGCTGGGGCAGGACCCAGGCCCCGCCGCACATCGGCGCGGTCATCCGCGGGGCCATCGCGGGCGTGGTCCGCACCCGGCTCAGCCCTCGCCACTGA	MTGTRRGKTSGQYDVAILGSGMAGSMLAAVLARNGVEVLLVDQGTHPRFAVGESTIPYTSAMTRIIADRYRVPEIGALASFKGIQRHISRNSGIKQNFGFVYHREGRPQNPEEINQLKIPTALRTESHLYRQDTDAYLFAVAVRHGAHPRPGTRIEEVDIDPDAGVELRAAGGERFRAKYVVDAGGFRSPLADRFDLRENPTRARHHSRSLFTHMIGVRPFDAAPAAALHRQPSPWHNGTLHHVFDGGWLWVIPFDNHPGSTNPLCSVGLTLDPRRFPQEEPDPQREFDGFLKRFPEIAWQFTDAVATRPWVSTGRLQYSAKRLVGDRFCLTSHAAGFIDALYSRGLTNTLDVVNALAWRLIAAAREDDWSTERFSYVETLQQGLFDVHDDLVYSSFVGFRDYELWNAVYRTWKIGTVLGTLVLENAHTAFLRTGDDGLFRELEQSDHPGSPFPISDQFNQFGPLTRELCLAVENGSLSPSAAAAKVFHHIEDADYIPPVFNLGDPANHFFHATPPKMLAAARWGRTQAPPHIGAVIRGAIAGVVRTRLSPRH	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	116.18	gnl|BL_ORD_ID|4833|hsp_num:0	5820			3	471	rifampin; rifaximin; rifapentine
BGC0001038.1|Pyralomicin_24 # 25707 # 30875 # -1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=AGGGA;rbs_spacer=8bp;gc_cont=0.759	BGC0001038.1|Pyralomicin_24 	25707	30875	-	Loose	750	88.1965	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	29.54	3003463	protein variant model	G387D	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGACACAGGCCGACCTTCGCGCCCGGCTCATCGAGGCGTTGCGGGTGATCGAACAGCTGGAGGGCAGGCTCGCCGCAGGCGGGTCCGCGCCGGAGCCGATCGCCGTCGTCGGGGCGGGCTGCCGCCTGCCCGGCGGCGTCGACGGGCCCGACTCGTTCTGGAAGCTGCTGAGCGACGGAACCGACGCGGTGAGCGAGTTCCCCGCCGGCCGCGCCGACCTGGCGGCCTGGTACGACCCCGACCCCGACCGGCCCGGCACCACCTACGTGCGCCACGGCTGTTTCGTCGACCAGGTGGACCGGTTCGAGCCCGAGGTCTTCGGCATCTCCCCGCGCGAGGCCATCGGCATGGACCCCCAGCAGCGGCTCGCCCTGGAGGTCGCCTGGGAGGCCCTTGAGCACGCGGGGTACGCGCCGGACTCCCTCACCGGCAGCGCCACCGGCGTGTTCCTCGGGGTGAGCACCACCGACTACGTCCGGCTGCGGCAGGAGCGCGGCGACCCCGCCGACGTGGACGCCTACCAGCTCATGGGCGAGCCCAGCTTCACCGCCGGCCGGATCTCGTTCGTCCTCGGGCTGATGGGGCCGAGCCAGGTCGTGGACACCGCCTGCTCGTCATCCCTGGTGGCGCTGCACGACGCCTGCCAGGCGCTGCGGCTCGGCGAGTGCGACATGGCGCTGGCGGGCGGCGTCAACCTCATGCTCAGCCCGTACTCGTTCGTGCTGCTCAGCAAGTTCCGCGGGCTGGCGCCCGACGGGCGGTGCAAGACCTTCGACGCCGCCGCCGACGGGTACGGGCGCGGCGAGGGCGCCGGCATCGTGGTGCTCAAGCGGCTCTCCGACGCAGAGCGGGACCGTGACCACGTGCTGGCGGTCATCCGCGGCACCGCCGTCGCGCACGACGGGCGCAGCAGCGGCATGACGGTGCCCAATCCGGCCTCCCAGCAGGCCGTCATCAGGGACGCGCTCAAGCAGGCCGGCCTGACCCCGGCCGACATCGACTACGTGGAGGCCCACGGCACGGGAACCGCGCTCGGCGACCCGATCGAGCTGCGCGCGCTGCAGGCGGTCATCGGGCAGGCGCACAGCCGCGCCGCCCCGCTCCTGGTCGGCTCGGTCAAGACGAACATCGGCCACCTGGAGGCCGCCGCGGGCGTCGCCGGGCTGCTCAAGGTGGTGCTGTCCCTGCACCACCGGGAGATCCCGCCGCATCTGCACTTCACCGACCCCAACCCGAACGTGGACTGGTCAGGGCTGCACGTCCGCGTCGCCGACGAGAGACGGCCGTGGCCGGTGCGCGGCGGCGTGCGCGCGGGCGGGATCAGCAGCTTCGGCGCCAGCGGGACCAACGCCCACGCCGTGGTCACCGAGCCGCCGCCGCGTCCGGTGCCCGCCCAGGCGCCCGGGCCGCGGCGCGAGCACGGCGTGCTGACGCTGTCGGCGCGCACCGAGGGCAGCCTGCGCGAGCTGGCCAAGGCGTACGCCTCCTGGCTCAGGACGCCGGGCACCGGGTCGATCGAGGACGTCTGCCGCACCAGCCAGAGCGGGCGCGGCAGGATGGCCAAGGGGCTGGCCGTCGTCGGCGACTCGTCCGCGGAGCTGGCGCGGGCGCTGGAGACGTTCGGCCGCGGCGAGCACGACGACGGCTGGACGGGCGTCGCGCTCGCGCCGCACCGCAACCGCGGTCTGGCCTGGCTGTTCACCGGCCAGGGCGCGCAGTACGGGCGCATGGGCGAGGATCTGCGCGCCGAGCCGGCCTACCGGGAGGCGATCGAGCGCGTCGCCGAGCTGATGGACCCGCTGCTCGACCAGCCGTTGGCCGCGCTGCTCGACCTGCCGGACGACGCGGGCTCCCCGATCCACCTGACCGGCAACACCCAGCCGGCGCTGTTCGCCGTCGAGTACGCGCTGTCGCGGCTGTGGATGTCCTGGGGGGTGCGGCCCGCCGTCGTCATGGGGCACAGCGTCGGGGAGATCACCGCGGCTTGCGTGGCCGGGGTGCTCAGTCTGCCCGACGCGGTCGAGCTCGTCGCCGCCCGCGGCCGGCTCATGCAGGCCCTGCCCGCGGGTGGCGTCATGGCGACCCTGGTCTGCGACGAGGAGCGGGCGCTGCGGGCGATCCAGGGGTTCGAGGAGCTGGTCTCGGTGGCGGCGGTCAACGGCCCCGCCGACACCGTCATCGCGGGCCCGGCCCGCGAGGTCGCCCGGATCACCGACGCGCTGGCGGCCGAGGGCGTCAAGCACCGCCTGCTGAAGGTGTCCCACGCCTTCCACTCGCCGCTGCTGAAGCCGATGCTGGACGACCTGCGCGCGGTGGCCAGAGGCGTCAGGCATCACGAACCGGAGATCCGGCTGCTGTCGAACGTGACCGGCGACGAGTGGGGTGAGGAGCAGCGCGACCCGGAGTACTGGGTGCGGCACGCGCTCGCGCCGGTCCGCTTCCACGACGGGATCCGCCGGCTGCACCGCGACGGCCTGCGCACCTTCCTGGAGATCGGCCCGCAGCCGGTGCTGCTCGGCCTCGGCGCCCGGGCCCTGGACGATCCCGGCTGCCTCTGGCTGCCGTCCCTACGCAAGAACCATGACGGACGGCGGCGCACGATCGCCGCGCTGGGCGCCCTGCACCTGCGGGGCGTCGCGGTGGACTGGGCCGCCGTCCACGGGGGAGCCGGGTTCGACCGGGTGCCGCTGCCCACCCACGTGTGGGACCGGACGCGGCACTGGTTCACGGAGGTGGAGCCGGGCGCCCCGGTCATGCGCGGGCGGCCCGGCGCATCGGGCCCCGGCGTCCGGCTGCCGGTCGCGCTCCCCACCTATGAGGTCGCCGCGGACGCCGAGGCGGGGCTGGAGCGGCTGGTCGAGCTGGCCAGGCAAGCCGCGGCGGATGCGTTCGGCGGCGTTTGGCACCGGGCCGCCGCTGTGGAGCTGGCCGAGCCGGTGGCCGCCGGTCAGACCCTTCAGGTCACGGTCGAGCGGGACGGCGACGGCCCGGCCGCGTTCACCGTCAGGGGCCGCGACGACGGCGAGGCGGCGGCGTCGGCCCCCTGGCGCCTGCACGCGCGCGGCGTGCTCCACGGCGGGGCGGTCAGGGAGAGCGACGGGATCGACGGCGACGAAGACGTGGTGGTGCCGGCCGGTGAGCGTCATCCGCTGGTGGCCGCCGCCGTGGCGCTGAGCGGCGCGGAGACGGCCACGCCGGCCGGATTCGAGACACTGGCCTGGGACCCGGGCCCGCCCGTGGCGAGCGTGCGAGTACGCAGGCGGAGCGCCGAGGCCGAGTTCCGCACCGCCGGCGGCCGCGTGAGCGGCCGGGTCACCGGGCTGCGGACGGCGCAGCCGGGCGAACAGGCCGCCGCGCGCTGGCGCGACCCTGCCGAGCTGGTGTTCGAGCTGGACTGGCAGGAGGCGCCCCTGCCCGCGGCGGGCGGCCTCGACGGCGAGCGCTGGCTCCTGTTCCGCGACGGCCACGGCGTCGCCGAGCGGCTGGCCGAGCAGGTGCGCGAGCAAGGCGGACACCCGCGGCTGGTCCGCCACGCGCCCGGGGTGGGCGTGGCGGGGCTGCTCGCCGAGGGGCGGCCGCACCGGGTCGTCGTCCTCACCGGGCTCGACGCGCCCGACCTGGACGAGGCCGACGAGGACGCGCTGGTGGCCTTCCGCGACCAAGCCGAGCTGCTGGCCGTCGAGGTCGTCCAGGCGCTGCGCGACCGGCCGGGCGTCACCGTGCACCTGGTCACGCGCGGCGCGGTGCCCGCCGCCCCCGGCCGGCGGCAGCACCGGGCGGCGGCCGCCGGGCTGTGGGGGCTGGGCCGGGTGATCGCGCTGGAACATCCGGGCCTGTGGGGCGGCGCCGTGGACCTGGACCCGGCCGGACCGGCCGACGGGACCGGGCGCCTGCTTGACGCACTCGTGCACAGCGCGGAGGACCAGATCGCCCTGCGTGAGGCCCGGGCGCTGGTGTGCCGGCTGGTCCGGCGACCCTTGCCGGCCGAGCGGCTCCAGGCGGCGCCGCCCATCCGCGCCGACGGGGCCTACCTGGTCACCGGGGCGTTCGGCGGAATCGGCGTCACGGTGGCCCGATGGCTGGCCGGGCACGGCGCTCGGCGGCTGGTGCTGCTCGGCCGGACGGCGCTGCCGGAGCGGGAGCGCTGGGACGACCCTGGCCTGACGGCGGCGCAGACCGAGCGGATCGCCGTAGTGCGAGCCCTGGAGGCGCTCGGCGCCGAGGTCACCGTCGAGGCGGCGGACGTGGCCGACGCCGCCGCGGTCCGCGCGGCCGTGGCCCGCCTGGAGGCCGGCGGCGTGCCGCTGCGCGGCGTGGTCCACGCGGCCGGCGTGTCCAGACCCCAGGTTCTCGCCGAGGTGGACCGGGCGGGCTACGCGGCGGTCTGGCGGCCCAAGGTGCTGGGCGGGTGGGCGCTGCACCGCGCCACCCGGGAGTCGGAGCTGGACTTCTTTCTCGGCTTCTCCTCCATAGCTGCCGCCTGGGGCTCTCTCTACCTGGCCGGTTACGCCGCCGCCAACGCCTTTCTCGACGGCCTGGCCCAGGACCGCCGCGCGCGCGGGTTGCCCGGTCTGAGCGTGGACTGGGGGCAGTGGGAGCTGCCGTCCAAGCTGTACGGGGCGGACGTCCGCTCGTTTCTGGCCGCCAGCGGGCTGCGGGCGCTGCCCGCCGGGCAGGGGCTCCGGCTGCTGGGCGCCTTGCTGGGGGCGGACCGGGTCCAGCCGGTGGTGTGCGCGGCGGACTGGCCCGCCTACAAGGCGACGCTGGAGATCCGCGGCCCCAAGCCCGTGCTGGAGCAGGTCGAGGCGGCCCAGGCGGCCGAGGAGCCGGCGGGCGAGGCGGCACCGGTGCTGGAGGAGCTGCGCGGCTGCCCGCCGGACGAGCGGCCGGCCGTCGTCTCCGGCTACCTGCGTGACCAGCTCGCGCAGATCCTCGGCCTGGAGCGGTCGCGGCTCGACACCGAGTTCCGCCTGCTCGACCTGGGCATCGACTCGCTGATGGTGATGGAGCTGATCAGGCGGGTGCGGCGAGACCTGCGGATCGACTGCCCCGCCAAGGACTTCTTCGCCACCGACGCCGCCGAGTGGGACACGCTCCTGCTCCGGCAGGCAGCACAGCACCACGCGTTCGACATGTCCGCTACCGAGGTTGGGAGTGACGACAGGTGA	MTQADLRARLIEALRVIEQLEGRLAAGGSAPEPIAVVGAGCRLPGGVDGPDSFWKLLSDGTDAVSEFPAGRADLAAWYDPDPDRPGTTYVRHGCFVDQVDRFEPEVFGISPREAIGMDPQQRLALEVAWEALEHAGYAPDSLTGSATGVFLGVSTTDYVRLRQERGDPADVDAYQLMGEPSFTAGRISFVLGLMGPSQVVDTACSSSLVALHDACQALRLGECDMALAGGVNLMLSPYSFVLLSKFRGLAPDGRCKTFDAAADGYGRGEGAGIVVLKRLSDAERDRDHVLAVIRGTAVAHDGRSSGMTVPNPASQQAVIRDALKQAGLTPADIDYVEAHGTGTALGDPIELRALQAVIGQAHSRAAPLLVGSVKTNIGHLEAAAGVAGLLKVVLSLHHREIPPHLHFTDPNPNVDWSGLHVRVADERRPWPVRGGVRAGGISSFGASGTNAHAVVTEPPPRPVPAQAPGPRREHGVLTLSARTEGSLRELAKAYASWLRTPGTGSIEDVCRTSQSGRGRMAKGLAVVGDSSAELARALETFGRGEHDDGWTGVALAPHRNRGLAWLFTGQGAQYGRMGEDLRAEPAYREAIERVAELMDPLLDQPLAALLDLPDDAGSPIHLTGNTQPALFAVEYALSRLWMSWGVRPAVVMGHSVGEITAACVAGVLSLPDAVELVAARGRLMQALPAGGVMATLVCDEERALRAIQGFEELVSVAAVNGPADTVIAGPAREVARITDALAAEGVKHRLLKVSHAFHSPLLKPMLDDLRAVARGVRHHEPEIRLLSNVTGDEWGEEQRDPEYWVRHALAPVRFHDGIRRLHRDGLRTFLEIGPQPVLLGLGARALDDPGCLWLPSLRKNHDGRRRTIAALGALHLRGVAVDWAAVHGGAGFDRVPLPTHVWDRTRHWFTEVEPGAPVMRGRPGASGPGVRLPVALPTYEVAADAEAGLERLVELARQAAADAFGGVWHRAAAVELAEPVAAGQTLQVTVERDGDGPAAFTVRGRDDGEAAASAPWRLHARGVLHGGAVRESDGIDGDEDVVVPAGERHPLVAAAVALSGAETATPAGFETLAWDPGPPVASVRVRRRSAEAEFRTAGGRVSGRVTGLRTAQPGEQAAARWRDPAELVFELDWQEAPLPAAGGLDGERWLLFRDGHGVAERLAEQVREQGGHPRLVRHAPGVGVAGLLAEGRPHRVVVLTGLDAPDLDEADEDALVAFRDQAELLAVEVVQALRDRPGVTVHLVTRGAVPAAPGRRQHRAAAAGLWGLGRVIALEHPGLWGGAVDLDPAGPADGTGRLLDALVHSAEDQIALREARALVCRLVRRPLPAERLQAAPPIRADGAYLVTGAFGGIGVTVARWLAGHGARRLVLLGRTALPERERWDDPGLTAAQTERIAVVRALEALGAEVTVEAADVADAAAVRAAVARLEAGGVPLRGVVHAAGVSRPQVLAEVDRAGYAAVWRPKVLGGWALHRATRESELDFFLGFSSIAAAWGSLYLAGYAAANAFLDGLAQDRRARGLPGLSVDWGQWELPSKLYGADVRSFLAASGLRALPAGQGLRLLGALLGADRVQPVVCAADWPAYKATLEIRGPKPVLEQVEAAQAAEEPAGEAAPVLEELRGCPPDERPAVVSGYLRDQLAQILGLERSRLDTEFRLLDLGIDSLMVMELIRRVRRDLRIDCPAKDFFATDAAEWDTLLLRQAAQHHAFDMSATEVGSDDR	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	413.94	gnl|BL_ORD_ID|1968|hsp_num:0	1943			429	1224	isoniazid
BGC0001038.1|Pyralomicin_25 # 30872 # 33112 # -1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=8bp;gc_cont=0.759	BGC0001038.1|Pyralomicin_25 	30872	33112	-	Loose	600	26.1794	LMB-1	38.71	3005018	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	LMB beta-lactamase	ATGGCCACGCCGACGATCTTCCGGGCCATGTCGGCCGGCGGCGCGCTGTCCAGGGACGGCAGGTGCAAGACGTTCGACGACGCCGCCGACGGCTACGGCCGGGGCGAGGGCGCGGGTGTGGTCGTGCTGAAGCGCCTGTCCGACGCGCTGCGCGACGGCGACCGCGTGTTCGGTCTCATCCGCGGCAGCGCGGTCAACCAGGACGGCGCCAGCGGCGGACTGACCGTGCCCAGCGGTGCCGCCCAGGAGGAGGTCATCGGCGATGCGCTGCGCCAGGCGGGGCTGCGGGCCGCGGACGTCGGCTACGTCGAGGCGCACGGCACCGGAACCAGGCTCGGCGACGCCATCGAACTGCGGGCCCTGGCCGCCGCGCTCCGCCCGGAGGGCACCGCGGAACGGTCGCTGCTCGTCGGGTCGGTCAAGACCAACATCGGTCATCTGGAGGCCGCAGCCGGGGTCATCGGCCTGATCAAGGTCCTGCTCGCCTTCGACCGCGAGGTGATCCCCGCCCACCTGCACTGCGAGGTGCCGACGCGGCAGCTCGCCTGGGACCGGCTCCCGTTGCGCGTCACCACCGAGCAGGTGCCCTGGCCGAGGGCGTCCGGCACGCGTGTCGCCGGGGTGAGCGCCTTCGGGTTCACCGGTACGAATGCCCATGTCCTCGTCCAGGAGCCGCCGCCCGCCGGCGAGAGGTCCACGGCTGCCGGGACCGGCCCGGCGCTGCTGGCGGTCTCGGCCCGGACGGCGCCCGCGCTGGAGGAGGCCGTCTCGCGGCTGCGCGAGCGGCTGGCCGCCACGCCGGAGGCGGACCGCGCGGACCTGTGCTGGACCTCCGTCGCCCGGCGGATCCACCATGAGCACCGGATCGCCGTGGTGGGACGGACCGTCCGGGAGCTGGCCGAGGCGCTGGGCGCGGGGCCGCACCGCGGGCACGTGCCCGCGGGGGAGGAGCGCCCCGTCCTGTTCCACCACCGTGCCAGCCCGCCGAGCCGGCAGTGGTTCGCCGAGGTCACGCGGGAACTGCCGGGCATCGACGCGACGCGCATCCTGGAGCGCACCGAGACCGAACTACGCACCGTGGCCGCGCCGCGAACCGCCTCCGGAAACACGCCGCGAACCGCCCCCGGAAACGCGCCGGGGACAGCGCCGGGGACCGGGGCGGAGTCGCCGGCGGGAATCGAGGTGCTGGCTCGGCACGTGGCGGCCGTTCGCCTGTGGCGGGCGCTGGGCGTGGTGCCCGCCGCCGTGGCTGCGCCTCCGGATGTCGGTCCCTACCTGGCGGCCTTCGCGGCCGGTGAGCTCACCGTCGCGGAGCTGGCCCGGGCGTTCGCCGAGGGGACGCCGCCGCGCGCCGGCGGCGTCCCCTCCTTCCCCGACCTGGCCGCCGCCGCCGGGTTCGAGCTGGTGCTCGACCTCGGTGAGCACGGGTGCGCGGTCAGCCTGACCGGCGAGGCAGCCCGTCCAGGAGCCCCAACCGCCAGCGAAGCCGGCGGTGGGGTCGGGGCCGACGGCGGGGCGGAGGCGCTCGATGTGCTGGCCGCCCTGCACGTGCGGGGGGCGCGCCTTGAGTGGGGGCGGCTGGCTCCCGCCCGTCCGCGGGTGCTCTCCCTGCCCGCCTACCCGTGGCAGCGCACGCGGCACTGGGTGGAGGCCGTCGAGACGCCACCGCCGCCGGCCGCCGGGCCGCGTGCAGACGGGCCGCCCGGCAGCGGATCGGAGCCGGGGCCGCCCGTGGAGACCACGCTGCTGCGCCGCATCCGGGCCACGCCCGCGCCGGCGCGGGTGGAGGCGCTGCTGCCACCGCTGCTCGACCTGGTCGCCGAGGTGCTCGGCGGCGCCGACGACATCGATCCTGACCAGGGCTTCTTCGACATGGGCATGGACTCGGTCCTGTCGTTGCGGCTCAAGCTCGCCACCGAGGCGGCGCTCGGCATCGACCTGCCCAACACCGTCCTCTTCGAATGCCCCACCCCCCGCTCCTTCGCCCAGTTCATCGTCGCCGGCCTGGACGAGGCGCCGGCCGTGGACGGCACCGTGGACGACGCCGTGGACGACGCCGTGGACGAGCTCGCCGCGCTGAGCGACGACGCGCTCGCCGCCCGGGTCGCGGACGTGCTCGCCGGCTCCTCGGCCCGGCTGCGATCGGCCGAGGCCCCGGTCGCGGGGGTTCAAGCCATCTTTGAGCAGCCGCACGTTGACTCGGGTCACTACCCGATCTCGTCGAAGGGAAGCGACGAATGA	MATPTIFRAMSAGGALSRDGRCKTFDDAADGYGRGEGAGVVVLKRLSDALRDGDRVFGLIRGSAVNQDGASGGLTVPSGAAQEEVIGDALRQAGLRAADVGYVEAHGTGTRLGDAIELRALAAALRPEGTAERSLLVGSVKTNIGHLEAAAGVIGLIKVLLAFDREVIPAHLHCEVPTRQLAWDRLPLRVTTEQVPWPRASGTRVAGVSAFGFTGTNAHVLVQEPPPAGERSTAAGTGPALLAVSARTAPALEEAVSRLRERLAATPEADRADLCWTSVARRIHHEHRIAVVGRTVRELAEALGAGPHRGHVPAGEERPVLFHHRASPPSRQWFAEVTRELPGIDATRILERTETELRTVAAPRTASGNTPRTAPGNAPGTAPGTGAESPAGIEVLARHVAAVRLWRALGVVPAAVAAPPDVGPYLAAFAAGELTVAELARAFAEGTPPRAGGVPSFPDLAAAAGFELVLDLGEHGCAVSLTGEAARPGAPTASEAGGGVGADGGAEALDVLAALHVRGARLEWGRLAPARPRVLSLPAYPWQRTRHWVEAVETPPPPAAGPRADGPPGSGSEPGPPVETTLLRRIRATPAPARVEALLPPLLDLVAEVLGGADDIDPDQGFFDMGMDSVLSLRLKLATEAALGIDLPNTVLFECPTPRSFAQFIVAGLDEAPAVDGTVDDAVDDAVDELAALSDDALAARVADVLAGSSARLRSAEAPVAGVQAIFEQPHVDSGHYPISSKGSDE	MTLAKSFRCFCLVTTLSSMAMLAGCGGTAPVTVLSPPPADWVNSCKDWDDWDKAGPPYRIYGNSYYVGTCGISAILITGDNGHILIDGATEAGAKVIAANIDRLGFSLRDVKLLLQSHEHFDHVAGLAQLQQQSGAKLLASPAAAPVLTSGVVAAADPQAGMHEPFPAVRVDGLVTAGQVVTLGKLSLLPVATPGHTPGALSWQWSSCEAGQCQVLVYADSLSPVSSDSYRFSEHLTYLNAYRASLHKLAALDCQILLTPHPSASNMRTRLQSSAGLTDTQGCVVYADAITQRLEQRLIKETTQ	245.39	gnl|BL_ORD_ID|2750|hsp_num:0	3761			207	300	
BGC0001038.1|Pyralomicin_26 # 33112 # 36882 # -1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=AGAGG;rbs_spacer=7bp;gc_cont=0.757	BGC0001038.1|Pyralomicin_26 	33112	36882	-	Loose	2000	31.187	Staphylococcus aureus mupA conferring resistance to mupirocin	29.63	3000521	protein homolog model	n/a	n/a	mupirocin-like antibiotic	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	ATGCCCGGATACGCGACGCAGCCGAGACCCGATGACGTCGCGGTGGTCGGAGTCGGATGCCGCTTCCCCGGCGGGGTGCGGACGCCGCAGGCGTTCTGGCGCGCGCTCCGCGACGGGAAGGACGTCCTGCAGCGGGTGCCCGCCGACCGCTGGGGAAGTGGCTTCCACCACGCCGATCGCGGACGGCCGGGCGCGATCACCTCCGACCAGGGCGGTTTCCTGCCGGACATCGACAGGTTCGACGCCGCCTTCTTCGGCATCTCCCCGCGCGAGGCGGCCGAGATGGACCCGCAGCAGCGGATGCTGCTGGAGGTGACCGCCGAGGCGATGGAGGACGCCGGCGTGCCGATGCAGCGGTGGGAGGGCAGCCGGACCAGCGTCCACCTGGGAATGCTCGGCTCCGACTACCTCCTGCTGCACACCAAGACCGCAGGCGCCGCGGCGATCGGGCCGCACTTCGCCACCGGCAAGGAGTTCAGCTTCGCGGCCGGCCGGATCGCCTACGTCTTCGGCCTGCGCGGGCCGTGCATGACGGTCAACACCGCCTGCTCCTCCTCGCTGACCGCCGTCCATCTGGCCTGCCGCGCTCTGCGCGACGGTGAGGTGGACACCGCGCTGGCCGGCGGCGTCAACGCGCTGCTGACGCCCGAGCTGTCGATCTTCATGAGCAAGGTCCAGGCGTTCTCGCCGAGCGGGCGGTGCCGGCCGTTCGACGCGCGGGGCGACGGCATCGTCCGCGGCGAGGGGTGCGCGGTCGTGGTGCTCAAGCGGTACGCCGACGCGGTGCGTGACCACGACCAGATCTACGGCGTCATCCTCGGCAGTGCCGTCAACCACGACGGGCGCAGCGCGGGCCTGACCGTGCCGAGCGCGGTGGCCCAGCAGGACCTCCTGCGCGCCGCGCTGGCCTCGGCCGGCGTGGACGCCGGCGTGCCGGGCTTTGTGGAGGCGCACGGCACCGGCACGCCCCTGGGCGATCCGCTGGAACTGTCGGCCCTGGCCGCCGTCCTGGGCAGCGGCAGGGCCGCCGGGGACCGGCTGCTCGTCGGCTCGCTCAAGGCCAACTTCGGGCATCTGGACGCGACCGCGGGCGTGGCCGGCCTGCTGAAGGCCCTGCTGGTGGTCCAGCACCGCGTCGTGCCGCGGCAGATCCACTTCGACACCCCGACCCCGATGATCGACTGGGCCGACAGCGGGCTTGAGGTGCCCAAGGAGAACGTCCCGCTGCGCGGGCCCGGGGTGGCGGGCGTCAGCTCCTTCGGCCTGTCGGGGACGAACGTGCACGTCGTCGTCGGCGCGGCGAGCCCCGCCGAGCCGGCGTCGCCGTCCGCGCCCGCCGGCCCGGCGACCCTGCTGATCTCGGCCTCCACCGCCGAAGGGCTGCGCGAGCTCGCGGACGACTACCTGGACCTGCTGCGCGACGACGCCGATCTCGACGGGACGGTCGGGGCCGCCGCGGCCCGCCGTACCCACCGCGAGCACCGGCTGGCCGTCGTCGGGGCCGACGCGGCGCAGGTGCGCGGCGGGCTGACGGACTTCCGCGGCGGCGGCAAGAACAGCGCGGTGATGACCGGCGCGGCGCGGCTCGCCGAGGCCCCCGTGGTGTACGCCTTCTCCGGGCACGGCGCGCAATGGCCGAGGGCCGGCATGGACGTCTACGACGACAATGCCGTCTTCCGCGACATCCTCGACGAGTGCGACGCCGAACTACGCGCGCACAGCGGCTGGTCGGTGGTGGACGTGCTGCGCGACCCGGACCCCGCCCGGTTACAGGCGACCGCGACCGGACAACCGGCGCTGTTCGCGCTCCAGCTCGCCCTGGCCGGGCTGTGGCGCTCCTGGGGAGTGCGGCCGGCGGCGGTCGTCGGGCACAGCATGGGCGAGATCGCGGCGGCGTGCGTGGCCGGGGCGCTGTCGCTGCCGGTGGCCGCGCGGCTGATCGTCGAGCGCAGCACGGTGCTGGAGCAGGCCAAGGGGAGCGGCGCCATGGCCTCGGTCGACCTGGGCGCCGACGCCGCCCGAGAGTGGCTGGCCCGGCGCGCCCCGGAGGTGTCGGTCGCGGCGGTGAACGGCCCGCGCTCGGTCGTCGTCAGCGGCCCGGCCGAGGACGTCGCCCGGGCCGTGCGCGACTGGCAGCGGGAGAAGGTCGGGGCCGTCGCTCTGTCGGTCGAGTACCCCTCGCACGGGCCTCTGATGCGGCCCTACGGCCGGCGGCTCAGGCAGGCGACGGCCGACCTGGCCGCGTCCGCGCCGGCGATCCCCTTCCTGTCCACGGTCGATCCGGGGACGTCGGGTGGCGTGCCGGACGCCGAGTACTGGGAGCGCAACCTGTGCCGGCCCGTTCTGTTCTGGCCCGCGATCGATCGTCTGCTGGCCGAGCGTGACGCCGCGTTCGTGGAGATCGGGGCGCATCCGGTGCTGTCCCGCCCGGTCCGCGACGCGCTGGCCAGACGCGGCCGGCGCGGGATCGTGGTGGGCTCGCTGGTGCGCGGCGAGAGCGGCCCCGCGATGCTGGCCCGGTCGCGGGCACGGCTGCACGTCGCGGGCGTGGCCGTCGACTGGGCCCGGGTCTGGAACGGGCCGGTCCGCGCGGTGAGCCTGCCGCCGCCGCGCTGGGCCGACGATCGTCACTGGCTGGCGGGGGTGGAGCGGGGAACGCAGTCCGCGCCCTCTCCCGCCCTGGCGGGCCCAGGACCCGGACCGTCCGGTGTCGCCTCCGGGACGGCGCCGGTGGCCGGGCCCGAGGCCGGGCCCGAGGCGGCCTCCGGTGCCGCGTCCGGAACGGCGTCACAGGCGGCGGACGTGCGGGTCGCCGCGCACGCGTTGCTCGCGCGGGTGCTCGGCCACCCCGAAGGCACGCGCTTCCCCGAACGGCGCGGGCTGGTCGAGCTGGGACTCGACTCGGTCGGCGCGGCGGAGCTCGCCGAAGGGCTGACCCGGGTGACGGGCCGGCCGCTGGACGCCGCCGACGTACTCTCCCACGCCACCCTCGCCGCGCTGACCGAGCACCTGTCGCGATCGGCGACGCAACCGGCGACCGCCACGTCGGCACCGGAACGGGAGAGCGCCGCGGTGGCGGGACCGCGGACCGCTACGGCGAGGACCACGCCCGGCCCGTCGGGCGGCGCGTCGGGTGTCGCGTCCGGAACGGCGTCACAGGCGGCGGATGGAGCGTGGACCGGTGATGACCCCGTCGCGGTCGTCGGGTTCGCCTGCCGGGTCCCCGGCGCGCAGGACAGCGACGCCTTCTGGTCCCTGCTGAGCGACGGCCGGGACGCGACCGGACCCGTCCCGCCCGGGCGCTGGGACGCCGAGCGCCTGTTCGCCGAGGGAGCCGTCGCCACCACGCGCGGCGGCTTCCTCGACGCGGTGGACGGCTTCGACCACGGCTTCTTCCGGGTCTCGGCCCGGGAGGCGCGCAGCATGGACCCGCAGCAGCGGCTCTTCCTGGAGACCGCCTGGGAGGCACTCGAACACGCCGGCCTCACCCTGCGAGAGCTGCGCGACAGCCGCACGGGGGTGTTCGTCGGCCTCAACTCCACCGACTACCAGCAGCTCCTGCTGGGCGGCGGCGCCGAGGTCGACCTGTACTACGGGACCGGCAACTCCTTCTCCGGGGCGGCCGGGCGGCTGTCGTACCTGCTGGGGCTGCGCGGGCCGAGCCTGGCCGTCGACACCGCCTGCTCCTCCTCGCTCACCGCGGTGCACCTGGCCTGCCAGAGCCTGCGGCTGGGCGAGAGCCGGGTCGCCGTCGCGGGCGGGCGGACGTGA	MPGYATQPRPDDVAVVGVGCRFPGGVRTPQAFWRALRDGKDVLQRVPADRWGSGFHHADRGRPGAITSDQGGFLPDIDRFDAAFFGISPREAAEMDPQQRMLLEVTAEAMEDAGVPMQRWEGSRTSVHLGMLGSDYLLLHTKTAGAAAIGPHFATGKEFSFAAGRIAYVFGLRGPCMTVNTACSSSLTAVHLACRALRDGEVDTALAGGVNALLTPELSIFMSKVQAFSPSGRCRPFDARGDGIVRGEGCAVVVLKRYADAVRDHDQIYGVILGSAVNHDGRSAGLTVPSAVAQQDLLRAALASAGVDAGVPGFVEAHGTGTPLGDPLELSALAAVLGSGRAAGDRLLVGSLKANFGHLDATAGVAGLLKALLVVQHRVVPRQIHFDTPTPMIDWADSGLEVPKENVPLRGPGVAGVSSFGLSGTNVHVVVGAASPAEPASPSAPAGPATLLISASTAEGLRELADDYLDLLRDDADLDGTVGAAAARRTHREHRLAVVGADAAQVRGGLTDFRGGGKNSAVMTGAARLAEAPVVYAFSGHGAQWPRAGMDVYDDNAVFRDILDECDAELRAHSGWSVVDVLRDPDPARLQATATGQPALFALQLALAGLWRSWGVRPAAVVGHSMGEIAAACVAGALSLPVAARLIVERSTVLEQAKGSGAMASVDLGADAAREWLARRAPEVSVAAVNGPRSVVVSGPAEDVARAVRDWQREKVGAVALSVEYPSHGPLMRPYGRRLRQATADLAASAPAIPFLSTVDPGTSGGVPDAEYWERNLCRPVLFWPAIDRLLAERDAAFVEIGAHPVLSRPVRDALARRGRRGIVVGSLVRGESGPAMLARSRARLHVAGVAVDWARVWNGPVRAVSLPPPRWADDRHWLAGVERGTQSAPSPALAGPGPGPSGVASGTAPVAGPEAGPEAASGAASGTASQAADVRVAAHALLARVLGHPEGTRFPERRGLVELGLDSVGAAELAEGLTRVTGRPLDAADVLSHATLAALTEHLSRSATQPATATSAPERESAAVAGPRTATARTTPGPSGGASGVASGTASQAADGAWTGDDPVAVVGFACRVPGAQDSDAFWSLLSDGRDATGPVPPGRWDAERLFAEGAVATTRGGFLDAVDGFDHGFFRVSAREARSMDPQQRLFLETAWEALEHAGLTLRELRDSRTGVFVGLNSTDYQQLLLGGGAEVDLYYGTGNSFSGAAGRLSYLLGLRGPSLAVDTACSSSLTAVHLACQSLRLGESRVAVAGGRT	MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKDLVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFNYEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQTALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSKIRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFVTNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEIIKLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPSHIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDEDIELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPADFIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELINKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNNEITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIGDSRGRFWEQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFINQALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELNIKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSLSSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKKKNLPINQRIDIYIGVTGELLESIKTNKNMFKENFVIKNIHLNVIDEYENTIHFNNKEIKISLLY	122.66	gnl|BL_ORD_ID|4699|hsp_num:0	2270			1827	1956	mupirocin
BGC0001038.1|Pyralomicin_28 # 37858 # 38178 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.657	BGC0001038.1|Pyralomicin_28 	37858	38178	+	Loose	400	25.409	VIM-49	29.49	3005497	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	VIM beta-lactamase	ATGGCCGGCATGGAGCAGACACATCCGGACCTTCAGCGGGCGCCGGCCGGCGCCGTCGACCGCTCGCGGATCAACGCCGCGATCACCGATTACGTCAAGGTTCAGTTCCTCGACGAGGCCGAGCCGCTGTCCGAGCTCGACCAGGAGACCCCGCTGCTGGAGTGGGGGATCCTCACCAGCCTGAACACCACCATGCTGCTCAGTTTCATCCGCAGCGAGCTGGGGGTGCCCGTTCCGCTCACCCACATCACCTGGCGGAACTTCCAGAACGTGCGGGCCATCACGGACATGGTCTGCGAACTGTCCGCCCAGAACGCCTGA	MAGMEQTHPDLQRAPAGAVDRSRINAAITDYVKVQFLDEAEPLSELDQETPLLEWGILTSLNTTMLLSFIRSELGVPVPLTHITWRNFQNVRAITDMVCELSAQNA	MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHISTQSFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRVGGVDVLRKAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHSTDNLVVYVPSANVLYGGCAVLALSRTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGHGLPGGLDLLQHTANVVTAHKNRSVAE	39.85	gnl|BL_ORD_ID|4627|hsp_num:0	5698			96	321	
BGC0001038.1|Pyralomicin_29 # 38210 # 39550 # 1 # ID=1_29;partial=00;start_type=GTG;rbs_motif=AGAGG;rbs_spacer=12bp;gc_cont=0.676	BGC0001038.1|Pyralomicin_29 	38210	39550	+	Loose	600	42.3578	Streptomyces venezuelae rox	26.95	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGGACGCCGTTTTCGACATCGGCATCATCGGCGGTGGCCCGGGAGGCGCGACGGCCGCCGCGTATCTGGCCAAGGCAGGTCTTTCCGTCGCCGTCTTCGAACGCGAGACGTTCCCCCGGGAGCACGTCGGGGAGTCCCTGGTCCCCGCGACCACTCCGGTGCTGATCGAAACGGGCTGCATGGAGAAGGTCGAGCAGGCGGGATTCCCGCGCAAGTACGGCGCGGCGTGGACCTCGACCGAGCAGCGGGACATCGACCAGATGGGCTTCCGCAACCTGACCAACGGCTTCCGCTCGGCAGAGGTGCTCTTCGCCGAACGCGACCAGTTGGGGGTCGACCGCGACTACACCTTCCACGTCGACCGGGGGCTGTTCGACCAGATCCTGCTGAAGAACGCCGAGAGCCTGGGCGCGAACGTCTTCCAGGGGGTTTCGGTGGGCGAGGTCGACTTCTCCGCGGAGCTGCCGGTCATGCACGTCCGGCTCGGCCGCGTGACCACGCCCGTACCGGTGCGCATGGTGGTGGACGCCAGCGGCCGGCGCACCCACCTCGGCAACCAGCTCAGGACGAAGGTCGTCGACCCGGTCTTCAACCAGTACGCCGTGCACACCTGGTTCGACGGGCTGGACCGCGGCGCGCTGACGGTGAACAAGGAGCAGTCCGACTTCATCTTCATCCACTTCCTGCCCGTGGCCGACACCTGGGTCTGGCAGATCCCCATCACCGACACCATCACCTCGGTCGGCGTGGTGAGCCAGCGCTCGCGCCTGCGCTCCTTCGACGGCGACCGGGAGAAGTTCTTCTGGGGCACCGTCGCCAGCCACCCCGGCCTGCTCGACGTGCTGAAGAACGCCGAGCAGGTCAGGCCGCTGAAGGCCGAGGGCGACTACAGCTACGGCATGAAGCAGATCATCGGCGACCGGCACGTGCTCATCGGCGACGCGGCGCGCTTCGTCGACCCGATCTTCTCCAGCGGCGTGAGCGTGGCGCTCAACAGCGCCCGTCTGGCCTCGCAGGACATCATCGCCGCTGCCGAGGCGGGCGACTTCGGCCGGCACCGGTTCACCACCTACGAGTCCACCCTGCGCCGAGCCATGCGTAACTGGTACGAGTTCATCTCCATGTACTACCGGCTCAACATCCTGTTCACTGCCTTCGTCCAGGACGACCGCTACCGCATCGACGTGCTGAAGATGCTGCAGGGCGACGTGTACGAGGACGAGCCCGAGATCCTCGCCACGATGCGCGAGGTCGTGCGGACCGTGGAGGCGGACCCGCACCACCTCTGGCATCCCTACCTGGGTAACCTCCGGGCCCCCGCCGCGGCGCCCGGATTCTGA	MDAVFDIGIIGGGPGGATAAAYLAKAGLSVAVFERETFPREHVGESLVPATTPVLIETGCMEKVEQAGFPRKYGAAWTSTEQRDIDQMGFRNLTNGFRSAEVLFAERDQLGVDRDYTFHVDRGLFDQILLKNAESLGANVFQGVSVGEVDFSAELPVMHVRLGRVTTPVPVRMVVDASGRRTHLGNQLRTKVVDPVFNQYAVHTWFDGLDRGALTVNKEQSDFIFIHFLPVADTWVWQIPITDTITSVGVVSQRSRLRSFDGDREKFFWGTVASHPGLLDVLKNAEQVRPLKAEGDYSYGMKQIIGDRHVLIGDAARFVDPIFSSGVSVALNSARLASQDIIAAAEAGDFGRHRFTTYESTLRRAMRNWYEFISMYYRLNILFTAFVQDDRYRIDVLKMLQGDVYEDEPEILATMREVVRTVEADPHHLWHPYLGNLRAPAAAPGF	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	93.70	gnl|BL_ORD_ID|4833|hsp_num:0	5820			0	357	rifampin; rifaximin; rifapentine
BGC0001038.1|Pyralomicin_30 # 40340 # 40471 # 1 # ID=1_30;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=5bp;gc_cont=0.750	BGC0001038.1|Pyralomicin_30 	40340	40471	+	Loose	650	20.7866	otr(C)	33.33	3002894	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGGGTGCCGGCCTGCGGGTCGGGGAAGCGGTGGCCGAAGACGGCGATCACCCGCTCGGCCCCGGTGCCGGGGAGCGCCAGTACATGATCCCGCTGTGGTCGGCGGCGGGCGTGACCGTGCGGACGTCGTAG	MGAGLRVGEAVAEDGDHPLGPGAGERQYMIPLWSAAGVTVRTS	MTRKTISNGARNAVEVRGLVKHFGEVKAVDGVDLDVREGTVLGVLGPXGAAXXRGALPAHVXGPDAGRRPWRFXTWCANRRALRRTIGXHRPVRXGRRESFSGRENLYMIGRXLDLSRKDARARADELLERFSLTEAAGRAAAKYSGGMRRRLDLAASMIGRPAVLYLDEPTTGLDPRTRNEVWDEVRSMVRDGATVLLTTQYMEEAEQLAHELTVIDRGRVIADGKVDELKTKVGGRTLQIRPAHAAELDRMVGAIAQAGLDGIAGATADHEDGVVNVPIVSDEQLSAVVGMLGERGFTISGHQHPSAQLXEVFLAITGQKTSEAADGGPQDGPQDQQGVQDKQYEEVPA	12.25	gnl|BL_ORD_ID|1952|hsp_num:0	1991			177	258	tetracycline
